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Abstract 
 
Playing a central role in cell signaling, G-protein coupled receptors (GPCRs) form the largest superfamily 
of membrane proteins and approximately a third of all drug targets in humans. The membrane potential is 
one of the defining characteristics of living cells. Recent work has shown that the membrane voltage, and 
changes thereof, modulates signal transduction and ligand binding in GPCRs. As it may allow differential 
signalling patterns depending on tissue, cell type, and the excitation status of excitable cells, GPCR voltage 
sensitivity could have important implications for their pharmacology. 
 
However, the structural basis of GPCR voltage sensing has remained enigmatic. Here, I present atomistic 
simulations on the Rhodopsin GPCR family, which suggest a structural and mechanistic explanation for 
the observed voltage-induced functional effects. The simulations reveal that the position of an internal Na+ 
ion, recently detected to bind to a highly conserved aqueous pocket in receptor crystal structures, strongly 
responds to voltage changes. The movements of a Na+ ion or a proton from the Na+ binding site gives rise 
to gating charges in excellent agreement with previous experimental recordings. 
 
Structural studies have revealed that inactive Rhodopsin GPCRs harbor a conserved binding site for Na+ 
ions in the center of their transmembrane domain, accessible from the extracellular space. Here, I show that 
upon the activation of GPCRs, a hydrated channel is formed between the Na+ binding pocket and the 
cytosol, thereby providing a conduit for Na+ egress to the cytosol. Coupled with the protonation change of 
D2.50, the Na+ ion movement occurs without significant energy barriers, and can be driven by physiological 
transmembrane ion and voltage gradients. I propose that Na+ ion exchange with the cytosol is a key step in 
GPCR activation. Further, I hypothesize that this transition locks receptors in long-lived active-state 
conformations. 
 
Biochemical studies on GPCRs have demonstrated that their basal signalling is allosterically modulated by 
pH. Here, I show that the global receptor conformation of the δ-opioid receptor and two constitutive mutants 
is tightly tied to the protonation state of two ultra conserved aspartate residues. I describe a sequential 
activation pathway linking the Na+ binding site and the D(E)R3.50Y motif to the activation of the receptor.  
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Chapter 1. Introduction 
 
Membrane proteins act as the initial checkpoint forming an interface between the cell and the external 
environment, mediating the transduction of a broad range of extracellular stimuli into a wide range of 
signalling cascades in the cell. The exceptional diversity of these receptors has allowed them to be sensitive 
to nearly every conceivable environmental stimulus: light, electrical, ionic concentrations, mechanical 
stresses, hormones, odorants, pH and proximity to other cells, to name but a few.        
 
Of particular importance are G-protein coupled receptors (GPCRs), which are named after by their ability 
to recruit and regulate the activity of intracellular heterotrimeric G-proteins. To date, these receptors are 
the largest superfamily of transmembrane receptors to be discovered with more than 800 members, involved 
in nearly every aspect of cell signalling. Due to their intrinsic roles, signal transduction by GPCRs is 
fundamental for the majority of physiological processes, from taste, smell and vision to endocrine, 
neurological and cardiovascular functions. Owing to this remarkable diversity, they are the targets of >30% 
of all therapeutic drugs.  
 
1.1 GPCR families 
 
The extensive diversification of GPCRs allows for a functional versatility not seen in many other protein 
superfamilies. There are over 800 distinct genes encoding GPCRs in humans, and they are classified based 
on phylogenetic criteria. In 1994, Kolakowski introduced the well-known A, Β, C and F classification 
system, used by the International Union of Pharmacology, Committee on Receptor Nomenclature and 
Classification (NC-IUPHAR)(1). It should be noted that classes D and E only exist in invertebrates and 
therefore will not be discussed further in this thesis. In 2003, this was updated by Fredriksson and 
colleagues to comprise of five main families. The major difference between classifications is the splitting 
of class Β receptors into disparate families (2). The five main GPCR families (shortened to GRAFS) are: 
Glutamate (class C), Rhodopsin (class A), Adhesion (class Β), Frizzled/Taste-2 (class F), and Secretin 
(class Β) (Figure 1-1, Figure 1-2) (please see below for a comparison of receptor families). Throughout the 
text I will refer to the GPCR families using the GRAFS nomenclature together with the extended 
Kolakowski classification system, the families will be referred to in italics and with a capitalised first letter 
(Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2 and Secretin) to prevent confusion with the receptors 
e.g. secretin and rhodopsin. 
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Figure 1-1: Phylogenetic relationship between GPCRs in the human genome 
The tree displays four of the 5 classes of GPCRs, the fifth class Rhodopsin is displayed below in section 
1.1.1.  This figure was adapted from (2). 
 
1.1.1 The Rhodopsin receptor family/class A 
 
The largest GPCR family is the Rhodopsin containing over 700 receptors (3). In contrast to the other GPCR 
families, their diversity lies within their TM region. Whilst they contain short N-terminal domains, there 
are a few exceptions. The protease-activated receptors (PAR1-4) contain a cleavage site within their N-
terminus, which, upon cleavage by thrombin/trypsin exposes its tethered ligand. In contrast, most 
Rhodopsin receptors are activated by interactions between the TM domains, extracellular loops and their 
ligand.   
 
The Rhodopsin family can be further divided into four phylogenetic subgroups: α, β, γ and δ, in which the 
greatest variation can be seen within the α and γ subgroups. Interestingly, there is no correlation between 
the phylogenetic group of the receptor and the endogenous ligand (2). For example, peptide-binding 
receptors are found amongst all four subgroups, whilst lipid-like binding receptors are found in three of the 
subgroups of the Rhodopsin family. However, some of the subgroups bind similar ligand types. For 
3 
instance, the α subgroup is composed mainly of amine binding receptors, all receptors in the β subgroup 
bind peptides and the glycoproteins and nucleotide binding receptors are within the δ subgroup (2). 
 
 
Figure 1-2: Phylogenetic relationship between the Rhodopsin GPCRs family in the human genome 
The tree displays four subgroups of the Rhodopsin GPCR family: α, β, γ and δ. This figure was adapted 
from (2). 
 
 
The Rhodopsin family to date includes most of the clinically relevant drug targets. The α subgroup contains 
more than 15 important drug targets including the histamine, dopamine, 5-hydroxytryptamine (5-HT), 
adrenoceptor, aminergic and prostanoid receptors. Current drugs, which target this subgroup are; 
antihistamines, antacids, cardiovascular and antipsychotics. The β subgroup mainly contains peptide-
binding receptors, and is the target for a range of hormones such as: oxytocin, gonadotropin-releasing 
hormone and endothelin. There are relatively few drugs for the β subgroup, due to the flexibility and the 
number of interactions the endogenous peptide ligands have with the receptors. These are difficult to 
recreate artificially, and small molecules are unable to mimic the full range of interactions required for full 
signal transduction. The γ subgroup comprises a range of important receptors, such as the opioid, 
somatostatin (SSTR) and angiotensin (AGTR) receptors. The opioid receptors are predominantly targeted 
for the treatment of pain, whilst the AGTRs are targeted by antagonistic drugs for the treatment of 
hypertension. The δ subgroup predominantly contains purinergic, protease-activated, glycoprotein-binding 
and olfactory receptors. These Rhodopsin sub-families are extensively reviewed in references 2 and 4.   
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1.1.2 Non-Rhodopsin families 
 
The Secretin family consists of only 15 members, predominantly involved in homeostatic functions. This 
family shares between 21% and 67% sequence identity amongst its members. Most of the variation is found 
within the N-terminal domain, which has been shown to be heavily involved in ligand recognition and 
binding by a plethora of experimental techniques. The majority of the Secretin family the N-terminal 
domain is stabilised by three highly conserved disulphide bridges (5). The Secretin family contains three 
ligand-binding domains, namely the proximal region, juxtamembrane region of the N-terminus and the 
extracellular loops in conjunction with TM6. Ligand binding is thought to form a bridge between the N-
terminus, transmembrane domains and extracellular loops, thereby shifting the receptor conformation to a 
more active state (6).    
 
The Adhesion family is the second largest family of GPCRs with 33 members, is separated from the Secretin 
family primarily based upon the phylogenetic analysis of the transmembrane domain as opposed to the 
structural differences between families. The distinction between families is further supported by the large 
differences in the architecture of the N-terminal domains. For instance the Adhesion family contain a GPCR 
proteolytic domain (GPS) in contrast to the Secretin family and the ligand preferences of the families also 
deviate with the Secretin family binding peptides and the Adhesion binding extracellular matrix molecules 
(2, 4, 7). The Adhesion GPCR family mediates the cytoskeletal organisation, thereby modulating the 
architecture of the cell. This facilitates the formation of dendrites in neurons as well as membrane shrinkage 
driving cellular rearrangements (for review see reference 43).    
 
The Glutamate family consists of 22 members, composed of metabotropic glutamate receptors (GRM), 
gamma-aminobutyric acid receptors (GABAR), calcium-sensing receptor (CASR), sweet and umami taste 
receptors (TAS1R1-3). Most of these receptors bind glutamate in a mechanism likened to that of the Venus 
fly trap (VFTM), where glutamate binds in a cavity formed between 2 lobes in the extracellular N-terminal 
domain (9). The transmembrane domain of Glutamate family is generally well conserved, and contains 
analogous motifs and microswitches to those present in the Rhodopsin family (see section 1.3). Amongst 
these is WL motif in TM 6, which aligns with its counterpart CWxP6.50, the PKxY aligns with NP7.50xxY 
motif in TM 7 (2, 4) (superscript numbers refer to the Ballesteros and Weinstein residue numbering system 
(51)).    
 
The Frizzled/Taste2 GPCR family includes two distinct groups, the Frizzled and Taste receptors. The 
frizzled receptors mediate signals from the secreted glycoproteins termed Wnt, these receptors have a long 
200 amino acid N-terminus which is thought to coordinate Wnt (2, 4). This family of receptors are 
predominantly involved in embryonic development, tissue and cell polarity (10). The function of these 
receptors in the Wnt signalling pathways is critical within the vertebrate central nervous system and has 
been implicated in the formation of neuronal circuits, such as synaptic assembly, dendritic development 
and axon pathfinding (11).        
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1.2 GPCR signalling pathways 
 
Receptors are a physical conduit for the transmission of extracellular binding information across the cell 
membrane, triggering intracellular signal transduction cascades. The classical model for GPCR activation 
and signalling, in which it was suggested that GPCRs activate heterotrimeric G-proteins and that the 
receptors are down-regulated by β-arrestin, thereby stopping signal transduction, has been shown to be 
severely oversimplified (12). In the last decade, it has been shown that GPCR signalling is much more 
complex and sensitive than originally thought. For instance, it has been demonstrated that there is an array 
of G-protein independent signalling routes involving the effectors (β-arrestin, ubiquitin, etc; see below for 
more detail). With the inclusion of a more greyscale approach to GPCR signalling it has been shown that 
individual ligands are able to bias the signalling pathway taken by their receptor (13).  
 
The activation of GPCRs thus triggers a diverse signal pattern along either G-protein-dependent or G-
protein independent signalling routes. These individual signal patterns modulate a range of downstream 
proteins, dependent on their intracellular binding partner. They can inhibit or stimulate downstream 
processes including: adenylyl and guanylyl cyclases, phosphoinositide 3-kinase (PI3K), phospholipase A2 
(PLA2), phospholipase C (PLC), phosphodiesterases and various ion channels. The modulation of these 
proteins leads to the production or inhibition of a plethora of secondary messengers; cyclic adenosine 
monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), diacylglycerol (DAG), inositol 
(1,4,5)triphosphate (Ins(1,4,5)P3), phosphatidylinositol (3,4,5)triphosphate (PtdIns(3,4,5)P3), arachidonic 
acid and phosphatidic acid as well as the changes in intracellular concentration of ions such as Na+, K+ and 
Ca2+ (Figure 1-3).  
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Figure 1-3: A schematic describing the downstream GPCR activation pathways 
 (Top) A vast range of ligands can bind to the extracellular domains of GRCRs, whereupon the GPCRs 
transmit this binding information across the membrane to the cytoplasm (only select examples shown). 
(Bottom) The GPCR can activate both G-protein dependent (green and blue) and independent (salmon) 
routes: The G-protein independent route can activate a range of kinases as well as regulating receptor 
turnover, while β-arrestin activation can also act as a scaffold for other signalling pathways. The activation 
of the G-protein trimer results in the dissociation of the Gα (blue) and Gβγ (green) subunits. Both the G-
protein dependent and independent routes have significant impact upon the cells response (silver).    
 
1.2.1 G-protein dependent signalling 
 
The canonical signalling pathway of GPCRs occurs via the binding and activation of intracellular 
heterotrimeric G-proteins composed of Gα, Gβ and Gγ subunits. In its basal state, the GDP-bound Gα 
subunit is in complex with the dimer Gβγ and is localised to the plasma membrane where it can interact 
with the activated receptor. GPCRs act as a GTP-exchange factor (GEF) for the G-protein complex. This 
results in conformational changes, leading to the exchange of GDP-GTP in the bound Gα subunit Figure 
1-4). Consequently the Gα and Gβγ subunits dissociate and can stimulate (e.g. Gαs) and/or attenuate (e.g. 
Gαi) their respective signalling pathways. 
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Figure 1-4: G-protein activation cycle 
Schematic representation of the G-protein activation process by GPCRs (red cylinders) and subsequent 
inactivation. (1) The trimeric G-protein (Gαβγ-GDP) in a prebound form with an inactive GPCR. (2) 
Agonist binding to the GPCR allows the receptor to act as a guanine exchange factor (GEF) exchanging 
GDP with GTP. Only upon the activation of the downstream effectors is the receptor deemed truly active. 
(3) Upon GDP-GTP exchange, the G-protein dissociates to Gα-GTP (3A) and dimeric Gβγ (3B). Both of 
these signalling proteins subsequently activate their respective pathways (Figure 1-3). (4) The GTP bound 
to the Gα is catalysed into GDP, releasing the phosphate into the cytoplasm. This process marks the 
inactivation of the Gα subunit. (5) After the catalysis of GTP to GDP, the subunits Gα and Gβγ recombine 
to form the inactive Gαβγ-GDP. Subsequently they can either reform the prebound complex or associate 
with the receptor after agonist binding.    
 
In humans, there are 21 Gα subunits encoded by 16 genes. The Gα subunits are separated into 4 classes: 
Gαs, Gαi, Gαq and Gα12, dependent on their primary sequence similarity (14, 15). The Gαs, Gαi are named 
after their ability to stimulate and inhibit, adenylyl cyclases, respectively. Whilst Gαq predominantly signals 
via phospholipase C (PLC) and Gα12 activates Rho family of GTPases. The modulation of adenylyl cyclases 
by GPCRs regulates the concentration of the ubiquitous intracellular secondary messenger cAMP, involved 
in nearly every signalling cascade (see Figure 1-3 for more details).  
 
The Gα subunit is composed of two domains: a 6-helix bundle unique to large Gα subunits, which forms a 
lid over the nucleotide-binding pocket burying the GDP within the core Gα, and a GTPase domain 
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conserved across all members of the G-protein superfamily. The GTPase domain hydrolyses GTP to GDP 
and provides a binding surface to the Gβγ dimer and the GPCR (16–18). An extended N-terminal α-helix 
can be covalently modified with fatty acids. Myristoylation is an irreversible covalent modification 
necessary for membrane attachment, whilst  palmitoylation is reversible and may have a role in the receptor 
bias between different G-proteins (19). The tip of the C-terminal α-helix coordinates with the active state 
GPCR within the core the transmembrane helices on the intracellular side (20). 
 
 
Figure 1-5: Structural representation of a trimeric G-protein 
The typical structure of a G-protein as exemplified by transducin. The Gα, Gβ and Gγ subunits are coloured 
in cyan, red and orange respectively. Figure adapted from (21) 
 
The process of GDP-GTP exchange in the Gα subunit upon activation by activated GPCRs is still very 
poorly understood. However, it is known that following the nucleotide exchange of GDP with GTP the γ-
phosphoryl group of the newly bound GTP results in a conformational rearrangement. The structural 
rearrangements occur within 3 switch regions, which are critical for the protein-protein interactions 
between Gα and its nucleotide state specific binding partners Gβγ (16–18). 
 
Gβ consists of an N-terminal α-helix and a β-propeller composed of 7 segments of WD-40 repeats. In 
contrast to the Gβ subunit, the Gγ protein is very small. The N-terminus forms a coiled coil interaction with 
the N-terminus of the Gβ subunit, whilst the remainder of the Gγ subunit coordinates with the outer edge 
of the Gβ toroid (22). The Gγ subunit is prenylated post-translationally at the C-terminus, receiving either 
a 20-carbon geranylgeranyl group or a 15-carbon farneryl group facilitating the membrane localisation of 
the Gβγ dimer (23). 
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Originally, the Gβγ subunit was thought to be involved in the inactivation of the Gα subunit, thereby acting 
as a negative regulator of Gα signalling (24). However, the Gβγ subunit has been shown to interact with 
many effector proteins including some, which are also modulated by the Gα subunits. With five Gβ and 
twelve Gγ proteins within humans, most Gβ and Gγ subunits can form dimers, the combination specificity 
between Gβ and Gγ subunits could contribute to the selectivity needed to generate the wide range of G-
protein signalling fingerprint. For example, Gβ1γ1 support binding of Gαt to rhodopsin whereas Gβ1γ2 does 
not (for review see reference 59).  
 
Whilst the activation process of G-proteins by their GPCR is currently unknown, recent crystal structures 
have revealed the possible binding modes of the G-protein and GPCR. In recent years, two mechanisms of 
interaction between the G-protein and GPCR have been proposed: the collision coupled model and the 
precoupled complex model. The collision-coupled model was originally proposed by Tolkovsky and 
Levitzki (26). Here, GPCRs and G-proteins interact by collision, whilst freely diffusing laterally on the 
plasma membrane. In this model only activated agonist bound GPCRs can couple to and activate their 
downstream processes. In contrast, the precoupled model proposes that the GPCR and G-protein exist in a 
prebound state before agonist binding (27). The physiological significance of this complex is entirely 
dependent on the rate-limiting steps of the downstream processes, as preassembly of the complex will have 
little effect on the inhibition of cAMP production (slow), while it will have a significant effect on the 
activation of ion channels in excitable tissue (fast). However it is becoming clear that a combination of the 
two occurs, which is highly dependent on the GPCR and G-protein subtype (28).  
 
1.2.2 G-protein independent signalling 
 
GPCRs are modulated by a multitude of mechanisms such as internalisation, desensitisation and 
interactions with cytosolic proteins. The aforementioned mechanisms are often mediated via 
posttranslational modifications (eg. glycosylation, palmitoylation, phosphorylation and ubiquitination), 
which in turn activate G-protein independent pathways, predominantly mediated by a small family of 
arrestins (Figure 1-6). However, it has been shown that ubiquitination has a far wider role in GPCR 
signaling than purely targeting activated receptors for lysosomal degradation.  
 
Arrestins are a family of four intracellular proteins (arrestin 1-4). Arrestin 1 and 4 are exclusively expressed 
within the visual rhodopsin system, in contrast, arrestin 2 and 3 are ubiquitously expressed and have since 
been renamed β-arrestin 1 and 2, respectively (29). The binding of arrestin 1 and 4 to GPCRs desensitises 
GPCR signalling, however only the binding of β-arrestin 1 and 2 results in the internatisation of the GPCR 
(30, 31). During the β-arrestin mediated internalisation of GPCRs, β-arrestins act as adaptor proteins for 
scaffold trafficking proteins clathrin, N-ethylmaleimide-sensitive fusion protein (NSF) and AP-2 (for 
review see reference 66). 
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Figure 1-6: Structural representation of β-arrestin  
The typical structure of a β-arrestin as exemplified by bovine β-arrestin 1 (33). Domains important for the 
binding to GPCRs (central crest) and activation (polar core and 3 element interaction) are highlighted.  
 
Ubiquitin is a 76 amino acid protein that is covalently attached to surface-exposed lysine residues. Three 
types of enzymes regulate the attachment of ubiquitin to its substrate: ubiquitin activating enzyme (E1), 
ubiquitin conjugating enzyme (E2) and ubiquitin ligase (E3). There are 2 major pathways involving the 
degradation of GPCRs: endosomal-sorting complex required for transport (ESCRT) pathway to lysosomal 
degradation and the ubiquitin proteasome system (UPS). GPCRs, which undergo agonist-induced 
ubiquitination, are predominantly internalised and are tagged for degradation, however once within the 
endosome they can be deubiquitination and redirected back to the plasma membrane (for review see 
reference 68).    
 
1.2.3 Biased signalling 
 
As described above, GPCRs are able to trigger a range of signalling pathways. However the specific subset 
of signalling pathways activated, is governed by individual ligands, an effect termed biased agonism 
(Figure 1-7). A balanced ligand would equally activate both the G-protein dependent and independent 
signaling pathways, whilst a biased ligand would activate one pathway preferentially over the other. 
Therefore, different ligands can have disparate efficacies (“pluridimensional efficacy”), and consequently 
drug efficacy cannot be measured in only terms of affinity and response magnitude, but the specific array 
of signals elicited from the receptor.  
 
The simple concept of agonist, antagonist and inverse agonist within the GPCR research field, has therefore 
led to the unexpected behaviour of some antagonists in the pharmaceutical industry. The introduction of 
biased agonism could explain distinct outcomes in patients treated with different antagonists for the same 
receptor. For example, Carvedilol, a common drug used in heart failure, is a G-protein antagonist. However 
it is also a β-arrestin and ERK biased agonist. In this case, it improves the therapeutic action of the drug 
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(35, 36). In contrast, Famotidine, an inverse agonist for the Gαs signalling pathway, also acts as a G-protein 
independent agonist, leading to the up regulation of histidine carboxylase and deleterious side effects after 
withdrawal (37).  
 
In recent years, a third signal class has been added to the G-protein dependent and independent signal 
patterns. It was originally thought that GPCR signalling occurs at the plasma membrane and was quickly 
terminated by receptor internalisation caused by β-arrestin binding, however the internalisation of some 
GPCRs after activation does not terminate their signalling processes. Instead, they have been shown to 
continue to signal via the Gα pathway from the endosome (38–42). Therefore, signalling via endosomal G-
proteins can be classified as new type of bias, as the signalling is temporally and spatially distinct from the 
canonical signalling present at the plasma membrane. As with the classical GPCR bias, different ligands 
have differential effects on the same receptor. However in this case, the ligands change the duration and 
location of the same signal pathway, thereby altering the distribution of secondary messengers with the cell 
(43). For example, parathyroid hormone (PTH) and PTH-related-Peptide (PTHrP) both modulate the PTH 
receptor, however, the dynamics of activation are vastly different, with only PTH inducing a sustained 
cAMP production via the early endosome, after a short exposure to the ligand (39).      
 
As previously mentioned, ligands are able to stabilise biased conformations. Interestingly, however ligand 
affinities are also allosterically modulated by the binding of β-arrestin and G-proteins (44). Therefore, it is 
important to note that the available subset of binding partners varies greatly across cell types as well as 
within the same cell under different conditions (45). Consequently, even if the same genetically encoded 
receptor was expressed in different cells and exposed to the same ligand, the biased responses might not be 
conserved across cells types and would display differential binding and/or signalling patterns.  
 
The mechanisms involved in biased signalling are to date unknown. Therefore, it is notoriously difficult to 
design ligands with a specific signal pattern (46, 47). Of particular note, opioid signalling is an excellent 
cultural, physiological and pharmacological example of the effects of biased signalling. In the case of μ-
OR signalling, β-arrestin 2 activation causes undesired side effects such as gastrointestinal dysfunction, 
respiratory depression and tolerance, whereas G-protein activation displays analgesic efficacy. The first 
clinical trial of the biased agonist TRV130, selective for the G-protein pathway binding to the μ-OR, 
produced analgesia in comparable levels to morphine whilst mitigating the unwanted side effects (48).  
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Figure 1-7: A schematic representation of biased signalling 
(A) A G-protein biased ligand is shown which predominantly activates the G-protein dependent pathway 
controlling secondary messengers shown in dark blue. (B) A G-protein independent biased ligand, where 
the β-arrestin pathway is predominantly activated. This leads to receptor internalisation, receptor trafficking 
(light blue) and the activation of a different set of secondary messengers (tan). 
 
1.3 Rhodopsin receptor family/class A structure 
  
As previously mentioned, GPCRs are composed of seven transmembrane helices and a horizontal helix, 
connected by either intra or extracellular loops. GPCRs are composed of three domains: The extracellular 
domain, consisting of the N-terminus and three extracellular loops (ECL 1-3); the transmembrane domain, 
consisting of the seven α-helices; and the intracellular domain, consisting of the intracellular loops (ICL 1-
3), an amphipathic helix (H8) and the C-terminus (Figure 1-8). 
 
 In the Rhodopsin family, the extracellular region regulates access of ligands to the core of the receptor. 
The transmembrane domain forms the structural core of the receptor, binding the ligand, and transmitting 
the signal through the membrane to the cytosol. Whilst the intracellular domain coordinates the binding of 
cytosolic effector proteins with the receptor, thereby helping to mediate the signalling specificity of the 
receptor.   
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Figure 1-8: The three domains in the Rhodopsin GPCR family 
Shown here are the three domains within the Rhodopsin GPCR family as exemplified by the M2R. The 
extracellular domain is highlighted in pink, the transmembrane domain is shown as blue helices and the 
intracellular domain is highlighted in green.  
 
1.3.1 Extracellular region 
 
The Rhodopsin family of receptors shows two distinct types of extracellular region. In most receptors the 
ligand binding pocket is accessible to the bulk solvent, whilst in others the ligand binding pocket is occluded 
such as in the rhodopsin, S1P1 and FFAR1 receptors. This has been proposed to be due to the access of 
ligand to the receptor from the lipid bilayer in these receptors (49). Of the three ECLs, ECL 1 and 3 are 
unremarkable short loops lacking any obvious structural features. In contrast, for receptors that bind water-
soluble ligands, the ECL 2 loop differs structurally throughout the family, though it is conserved in a 
subfamily specific manner. The secondary structure of the ECL 2 can contain helices (adenosine receptors), 
sheets (peptide-binding receptors) or can be disordered (muscarinic receptors). In all cases the ECL 2 
partially folds over the extracellular region, shaping the ligand entry pathway into the binding pocket within 
the transmembrane domain. The conformational flexibility of the ECL 2 is delineated by a conserved 
disulphide bridge, between residue C3.25 in the TM domain and ECL 2, which anchors the loop and thereby 
decreases its flexibility. In certain subfamilies, additional intra-loop disulphide bridges provide further 
structural stability and limit its conformational freedom (for review see reference 48).  
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1.3.2 Transmembrane Domain 
 
The helical bundle within the transmembrane domain acts as a physical conduit for the signal between the 
ligand binding site and cytosolic binding partners. An analysis of available GPCR structures has revealed 
a consensus network of 24 inter-helix contacts mediated by 36 topologically equivalent amino acids (Figure 
1-9). These contain the highly conserved residues: N1.50, D2.50, W4.50 and P7.50. However, in some positions, 
there is a high tolerance to amino acid variation, while predominantly similar non-bonded interactions 
between residues are retained. For example, the contacts between residue 2.42 and 3.46 are seen in all 
GPCR structures, while the sequence is highly variable. For instance, in bovine rhodopsin, they are 
isoleucine and leucine, whilst in κ-OR they are tyrosine and methionine, respectively. This consensus 
network is thought to provide an evolutionary structural scaffold of non-covalent contacts (for review see 
reference 15). The positioning of the inter-helical contacts is predominantly within the central TM domain 
and towards the cytoplasmic face of the receptor, primarily clustered between the helices 1-2-7, 2-3, 3-4, 
3-5-6. It has been proposed that TM3 provides a structural hub for the transmembrane region (Figure 1-9).     
 
 
 
Figure 1-9: Consensus scaffold non-covalent contacts within the Rhodopsin GPCR family 
 (A) A network of 24 inter-helical contacts between 36 topologically equivalent residues exists in GPCRs 
as exemplified by the inactive β1AR. (B) Schematic depicting the inter-TM contact network. The thickness 
of the lines denotes  the number of contacts between the TM helices. Figure adapted from (52).    
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A remarkable feature of the Rhodopsin family is the ability to coordinate highly diverse ligands, differing 
in chemical properties, shape and size. Throughout the Rhodopsin family, ligands bind in the extracellular 
portion of the transmembrane region, within a large hydrophilic pocket extending halfway through the 
receptor. In most receptors, the ligand-binding site is formed by a scaffold of the residues at 3.32, 3.33, 
3.36, 6.48, 6.51, 6.52 and 7.39 (Figure 1-10)(53). 
 
 
Figure 1-10: Ligand binding site within the m2 muscarinic receptor 
Three ligands bound within the M2R orthosteric ligand-binding site are shown. The ligands are bound 
within a cage of tyrosine residues. The two key ligand-binding residues within the m2 muscarinic receptor 
are D1033.32 and N4046.52. The receptor is shown in a top down view and hydrogen bonds between the 
ligand and receptor are depicted as black bars. 
 
1.3.3 Intracellular domain 
   
As discussed in section 1.2, GPCRs can bind a vast repertoire of intracellular binding partners such as G-
proteins, G-protein Receptor Kinases (GRKs) and arrestins. The intracellular section of the receptors is 
composed of three intracellular loops and a C-terminal tail. In some receptors such as the δ-OR, ICL 2 can 
contain an arginine, which forms a salt bridge with D3.49 at the end of TM3 anchoring the loop and therefore 
reducing the loop’s flexibility. In contrast to ICL 1 and 2, ICL 3 is disordered with no secondary structure. 
Finally, the C-terminal region is composed of an amphipathic helix (H8), typically 3 turns in length and a 
disordered section. The disordered section has been implicated in the pre-coupling of G-proteins, binding 
of arrestins and as a target for a variety of post-translational modifications (phosphorylation, ubiquitination, 
etc). 
 
1.3.4 GPCR domain evolution 
 
Of interest, there has been increasing evidence of a “bar code” present in the intracellular domain, in which 
each G-protein recognises a specific sequence of residues on the receptor (54). In contrast to the previous 
theory, it has perhaps unsurprisingly come to light, that G-protein binding is far more dynamic than 
previously thought. GPCR repertoires are thought to have been generated via gene duplication from an 
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ancestral receptor. Upon gene duplication, both GPCR copies are identical. However, over time these 
identical copies diverge, by accumulating mutations, in two predominant ways: (1) altering G-protein 
selectivity whilst maintaining ligand-binding properties (e.g. adrenoceptors; Figure 1-11, green bar), (2) 
altering their ligand-binding properties but retaining G-protein selectivity (e.g. olfactory receptors; Figure 
1-11, blue bar). In subsequent duplication events and further divergence, the receptors accumulate 
mutations allowing for different or additional G-protein and/or ligand binding (e.g. aminergic or opioid 
receptors) (55).      
 
 
Figure 1-11: A schematic depiction of the domain evolution of GPCRs 
Starting from an ancestral GPCR on the left, a gene duplication occurs, giving rise to two identical copies. 
Each copy accumulates different mutations modulating ligand specificity (green bars) and/or the G-protein 
specificity. After subsequent mutations the receptors might still couple to the same G-protein except have 
different binding characteristics. Adapted from (55).   
  
 
 
1.4 Rhodopsin receptor family/class A microswitches and motifs 
 
It is believed that there is a common activation mechanism within the Rhodopsin GPCR family (56, 57). 
Biochemical and crystallographic analysis of inactive and active states have been combined into a unified 
activation model termed “global toggle switch”. In this model activation the receptor undergoes a vertical 
see-saw movement pivoted around the Na+ binding pocket (section 1.4.2) during activation (58). The 
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extracellular portion (TM 6 and 7) of the receptor is thought to tilt inwards towards the orthosteric ligand 
binding site , whilst the intracellular portion (TM 6 and 7) tilts outwards opening a binding site for the 
intracellular effector (Figure 1-14). There have been many structural motifs and so-called “molecular 
switches” that alternate between substantially different conformations in the inactive and active states, these 
are proposed to be integral components of the activation mechanism. 
 
Here I describe the four most conserved: (1) Toggle switch – C/S/TWxP6.50, (2) Transmission switch – 
P5.50I/V3.40F6.44, (3) D(E)R3.50Y motif, (4) NP7.50xxY motif. The aforementioned motifs have all been 
implicated in receptor activation, however as yet, no consensus within the GPCR community exists as to 
the precise number or functional role of these motifs (Figure 1-12).  
 
 
 
 
Figure 1-12: Location of microswitches implicated in activation 
Depicted here are the four main microswitches conserved across the Rhodopsin GPCR family as 
exemplified by the M2R. The active conformation of the microswitches are shown in blue whilst the 
inactive are shown in orchre. In order of sequence, the toggle switch and transmission switch link the 
ligand-binding site to the Na+ binding site (see section 1.4.2). Below the Na+ binding site in the intracellular 
portion of the receptor are the NP7.50xxY and D(E)R3.50Y motifs. Also highlighted is the conformation 
change of TM 6 from the inactive (silver) to the active (blue). 
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1.4.1 Toggle switch (C(S/T)WxP6.50) and transmission switch 
(P5.50I(V)3.40F6.44) 
 
Within all crystal structures of the active Rhodopsin family receptors, several conserved residues are 
observed to change conformation in a concerted manner. The transmission and toggle switch link the 
ligand-binding site with the movement of TM 5 & 6 through a rearrangement of the interface between TM 
3-5-6. The original data and hypothesis originates from work on rhodopsin and β2A receptors, describing 
the movements of F6.44 towards P5.50, I(V)3.40 away from P5.50, and the rotation of W6.48. The toggle switch 
was originally proposed to alternate between two rotamer states (59, 60), however, the rotameric state and 
function of the residue has since been shown to be likely dependent upon the receptor and ligands studied 
(61–63). 
  
1.4.2 Na+ binding pocket 
 
The recently solved crystal structures of the A2A adenosine receptor, β1 adrenergic receptor, protease-
activated receptor and δ-Opioid receptor reveal a Na+/water cluster within the core of transmembrane 
bundle (Figure 1-14)(64–67). Crucially, these structures represent three of the four major branches (α, δ 
and γ) in the Rhodopsin GPCR family (see section 1.1.1). Interestingly, this pocket is highly conserved, 
both conformationally and chemically with a reported all atom RMSD of 0.8 Å, whilst the Na+ ion and 
surrounding waters shows an RMSD of 0.5 Å between the A2AAR (PDB: 4EIY) and β1AR (PDB: 
4BVN)(68).  
 
The δ-OR (γ-branch) shows a distinct variation in the Na+ binding pocket when compared to the previously 
mentioned structures. Whilst 15 of the conserved pocket residues are similar to the A2AAR and β1AR, the 
position 3.35 is the least conserved (Figure 1-13). In roughly 33% of receptors position 3.35 contains an 
asparagine, whereas in the majority of receptors within the Rhodopsin GPCR family, this position is 
occupied by a hydrophobic residue. Mutations of this residue dramatically alters the signalling of GPCRs 
in a receptor specific manner, for example within the δ-OR receptor the mutation of N3.35 results in a 
constitutively active β-arrestin biased receptor (65, 68).  
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Figure 1-13: Sequence conservation of the Na+ binding pocket 
(Top) shows the residue conservation in all non-olfactory Rhodopsin GPCRs, where the height of the 
residue letter corresponds to the frequency of the residue at this position. (Bottom) Individual residues are 
shown for some Rhodopsin GPCRs structures, conserved residues are highlighted in green. Greek letters 
on the right denote the 4 major branches of Rhodopsin GPCRs (section 1.1.1). Receptors in which Na+ 
binding has been determined by crystallography are in bold and marked with a ‘*’. The rhodopsin receptor 
which lacks the Na+ binding site is highlighted in red. Figure adapted from (68). 
 
These structures also provided a detailed description of the Na+ binding site within the Rhodopsin GPCR 
family. The ion is predominantly coordinated by the sidechain of D2.50 with four additional polar 
interactions with the receptor side chains (S3.39, N7.45) or water molecules. Interestingly, a retrospective 
analysis of previous inactive crystal structures strongly suggests that the electron density, previously 
modelled as water is compatible as a Na+ ion in many cases.  
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Figure 1-14: Conserved residues forming the internal hydrophilic pocket of Rhodopsin family of 
GPCRS 
(Top) Sixteen conserved residues (blue/red spheres) line the hydrophilic pocket in GPCRs (68). The pocket 
connects the orthosteric ligand-binding site and the G-protein binding site (black eclipses). The pocket is 
accessible from the extracellular side but separated from the intracellular side by a hydrophobic layer 
(yellow spheres) (69). Fifteen of the 16 residues are highly conserved (blue); the less conserved position 
3.35 is shown in green. At the allosteric binding site for Na+, water molecules are depicted as purple spheres 
(water oxygen atoms), and the Na+ ion is shown in red. The receptor is shown in side view on the left; the 
right panel displays a top view from the extracellular side. (Bottom) Close-up views of the binding site for 
Na+ (blue sphere) within the hydrophilic pocket of the wt δ-OR, N1313.35V δ-OR, and the wt M2R, as 
observed in our simulations. The binding site for Na+ in the M2R was inferred from the position and 
interactions of the ion in the wt δ-OR and the conservation level of the Na+ binding residues. Figure adapted 
from (70).  
 
In the protease-activated receptor 1 (Par1), the Na+ ion is predominantly coordinated by D2.50 and N7.49, 
though interestingly 7% of the Rhodopsin GPCR family have an aspartate at both 2.50 and 7.49. Many δ-
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branch GPCRs and most of the large olfactory receptors family (>380 receptors) contain a second acidic 
residue at position 3.39. Only 36 Rhodopsin GPCRs do not contain an aspartate at position 2.50 and of 
these 26 are described as non-signalling, decoy, putative, orphan or a pseudogene as described by the 
International Union of Pharmacology (IUPHAR) or UniProt databases. Interestingly, the receptors which 
do not contain an acidic residue at position 2.50, it is alternatively positioned at 3.39, 7.49 or 7.50. For 
example, the receptor GnRHR has an asparagine in position 2.50 and an aspartate at position 7.49. It has 
been shown that this receptor is still allosterically modulated by Na+ ions (see section 1.5.3), supporting the 
hypothesis that alternate acidic residues within the Na+ binding pocket are still able to coordinate Na+ (71). 
 
Upon GPCR activation, the Na+ binding pocket collapses from 200 to < 70 Å3 due to the inward movement 
of TM 7 and outward movement of TM 6 (68). These observations suggest that the activated Rhodopsin 
GPCRs are incompatible with Na+ binding. Therefore, although it has been shown by crystallography that 
the activation of the receptor abolishes Na+ binding, the question remains as to what happens to the Na+ ion 
upon activation and how it leaves the receptor. 
 
Studies into the Na+ binding pocket have shown that small mutations can lead to a pronounced signal bias. 
The point mutations D2.50A, N7.49A, N7.45A transform the classical δ-OR antagonist naltrindole into a β-
arrestin biased agonist (65). Furthermore, mutations of N3.35 to Valine or Alanine reduce and abolish Na+ 
binding, respectively. However, these point mutations create a constitutively active β-arrestin biased 
receptor, which cannot be modulated by ligand binding (65). These mutation studies on the δ-OR receptor 
provide support to the idea that the Na+ binding pocket has a strong role in regulating signal bias. 
 
1.4.3 NP7.50xxY motif 
 
The NP7.50xxY motif is located at the intracellular side of TM 7, bridging the hydrophobic layer which 
separates the Na+ ion-binding pocket and the transmission switches from the intracellular effector-binding 
site and the D(E)R3.50Y motif (see section 1.4.4). The residue N7.49 is highly conserved, however in some 
cases it can be replaced with an acidic residue such as in the GnRHR, in which the residues occupying 
positions 2.50 and 7.49 are switched (71). The Y7.53 is another highly conserved residue within this motif, 
and one of the major micro-switches for activation. In the inactive receptor conformation, the Y7.53 
sidechain is in an upward orientation bridging the hydrophobic layer and coordinates with the sidechains 
of N1.50 and D2.50 via a water molecule (Figure 1-12). Upon receptor activation, the sidechain of Y7.53 
changes its rotamer conformation from a vertical to a horizontal (65, 72) or downward (73) state interacting 
with TM 3, 5 and 6 (65, 72, 74).  This causes a rearrangement of the hydrogen bond network extending 
from the ligand binding site through the core of the receptor to the D(E)R3.50Y motif and effector binding 
site. Though not classified as part of the NP7.50xxY motif, the side chain of the highly conserved Y7.58 forms 
a water mediated hydrogen bond with Y7.53 when it resides in the horizontal conformation. Interestingly, 
this residue is located towards the intracellular section of TM V and has itself been crystallised in two 
conformations: either the sidechain faces outwards into the lipid head groups or inward towards the 
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NP7.50xxY motif. Both inward and outward conformations have been seen within inactive and active crystal 
structures (65, 72), leading to a lack of consensus as to the role of this residue, although point mutations of 
Y7.58 appears to contribute to the stabilisation of the inactive state (75, 76).   
 
1.4.4 D(E)R3.50Y motif 
 
The D(E)R3.50Y motif was first characterised in rhodopsin and was thought to be involved the formation of 
an ionic lock between the D(E)R3.50Y motif and E6.30/T6.34, stabilising the inactive structure. However, a 
similar glutamic acid or threonine is only present in 39 and 28% of the Rhodopsin family (14), respectively, 
and within those containing the requisite residues several do not form an ionic lock (77–79). In all inactive 
structures, R3.50 forms a salt-bridge with the preceding D(E)3.49, very likely stabilising the negatively 
charged form of the residue, and has been implicated in protonation change and activation (80). In the active 
state, R3.50 exists in an extended conformation projecting into the effector binding site, where it is proposed 
to be involved in G-protein binding and/or activation (62). However, in many X-ray structures the 
D(E)R3.50Y motif is not resolved at high resolution and it generally displays high B-factors, therefore 
rendering the analysis of the crystal structures inconclusive (20). However mutagenesis studies on this 
motif demonstrate its importance, as any mutation of R3.50 prevents the activation of G-proteins, thereby 
inhibiting the receptors ability to signal down this particular pathway (81).    
 
1.4.5 Motifs and their role in GPCR activation 
 
The microswitch motifs take a central role in the activation process of the receptor, though their functional 
aspects are still debated hotly. Two major models for receptor activation have been proposed; a sequential 
activation mechanism and the global toggle switch model. Many research groups attribute the activation of 
GPCRs to single residues, preferring to treat activation as a sequential process, propagating from the toggle 
switch located below the orthosteric ligand binding site through the Na+ ion binding site, NP7.50xxY and 
D(E)R3.50Y motifs to the effector binding site. This model requires that the agonist interact with key 
residues, leading to a domino effect through the receptor, before triggering the large conformational 
changes at the intracellular face. However, not all agonists bind within the orthosteric site, and so do not 
coordinate with these key residues (58). 
 
Alternatively to the sequential activation mechanism proposed above, a concerted action allosteric 
activation, as described in the global toggle switch model, has been suggested, based upon the Monod-
Wyman-Changeux model (82). The microswitches function as important components of the allosteric 
interface between domains or helices that perform the global conformational change during activation. The 
interface can then alternate between different states in which the side chains of the microswitches and water 
molecules are found in different interaction patterns. These distinct states of the allosteric interface can then 
stabilise different inactive and active conformations. An interesting advantage of the concerted activation 
model is that it does not require all the components of the microswitches to be present. Moreover, this 
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model allows for the possibility that different microswitch conformations or binding alters the allosteric 
interface stabilising slightly different active conformations, giving rise to the biased signalling present in 
GPCRs. This is supported by the bi-directional allosteric mechanism within GPCRs, where the ligand 
binding affinity is strongly influenced by G-protein binding at the cytoplasmic face (83).     
    
1.5 Physiological environment and its allosteric impact 
 
In any research undertaken on proteins, their physiological environment must be taken into account. In the 
case of integral membrane proteins such as GPCRs, this predominantly consists of the plasma membrane, 
pH, the transmembrane voltage, chemical gradients and ionic composition of the solution. The allosteric 
impact of each particular environment will be discussed below.  
 
1.5.1 Lipids and their allosteric modulation of GPCRs 
 
Throughout the biological world, a thin hydrophobic film of 30 Å thickness delimits the external 
environment and internal machinery of the cell. Inside the cell, specialised compartments, often containing 
important (nucleus) or toxic (lysosome) cargo are also delimited by their own membranes. One of the most 
important components of the cell is the plasma membrane, harbouring many essential cellular functions, 
such as: communication with the environment, transport of molecules and metabolic functions. The plasma 
membrane is composed predominantly of proteins (18-77% (84)), lipids and other small molecules (for 
review see reference 85). The lipid-protein interactions within the membrane are important as shown by 
(86, 87).  
 
From the ongoing classification of lipids, there have been over 40,000 different structures as of January 
2017 (LIPID MAPS Structure Database; LMSD)(88). Lipids fulfil many functions within the cell, these 
can be generalised into three main groups: first, in their reduced (saturated) state they are used for long 
term energy storage by many organisms whereupon β-oxidation they can feed into the citric acid cycle and 
electron transfer chain. Secondly, they function as a barrier, with the matrix of all membranes composed of 
polar lipids, consisting of a hydrophilic head group and a hydrophobic tail. Thirdly, lipids are able to act as 
secondary messengers in signalling cascades and molecular recognition processes. For a more 
comprehensive background see (89).   
 
As described previously, GPCRs exist as integral membrane proteins and as such it is likely that they can 
be allosterically modulated by lipid composition and density. Over the years, cholesterol has been shown 
to bind to GPCRs, with the first direct evidence of cholesterol binding shown in the crystal structure of 
β2AR (90). Despite a wealth of information, the allosteric effects of cholesterol are receptor-dependent, 
with reports of down and up regulation as well as direct and indirect effects (for reviews see reference 91, 
92). Recently, it has been shown that phospholipids modulate the activity of GPCRs. For example, a study 
on the β2AR, showed that negatively charged phospholipids shift the receptor into a more active state, whist 
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positively charged phospholipids stabilise the inactive state (93). In the crystal structure of β2AR, a high 
proportion of positively charged residue clusters at the receptor-lipid head group interface (90). It is 
therefore conceivable that the lipid allostery is also receptor specific, dependent on the charge distribution 
of residues. The modulation of the active conformation by lipids fits together with the proposed allosteric 
activation model.   
 
1.5.2 Modulation by pH and receptor protonation 
 
The pH within both the cytoplasm and the extracellular environments is strictly regulated to be between pH 
7-7.4 ( 
Table 1-1). However in certain conditions typically accompanied by inflammation and tissue acidosis (e.g. 
arthritis, tissue damage, etc.), the extracellular pH decreases to a pH of 5-7. In the specific situation of 
receptor signalling, tissue acidosis modulates the signalling patterns of proteins expressed on the cell 
surface. This can have significant effects on the protonation of ligands (94) as well as the function of GPCRs 
(95).   
 
Research by Kobilka et al has shown that the basal activity and agonist induced activation in the β2AR are 
pH sensitive, with greater activity at pH 6.5 than that at pH 8 (96). The majority of ionisable residues in the 
Rhodopsin GPCR family are solvent exposed and correspond either to arginine and lysine residues, which 
pKas are typically >= 10, or to glutamates and aspartates, which pKas are generally ~4. Such residues are, 
therefore, unlikely to be titrating under physiological pH conditions (~7). The only likely exceptions are 
histidine residues which typically titrate at pH 7. The Rhodopsin GPCR family contains three acidic 
residues within the transmembrane domain: D2.50, D3.32 and D3.49. Due to their buried position within the 
receptor, these aspartate residues are likely to have a higher pKa than that of a solvent exposed aspartate, 
and therefore have a higher probability of changing protonation state at neutral pH. The D3.32 is unlikely to 
be the pH sensor due to its relatively low conservation when compared to D2.50 and D3.49. Therefore only 
the aspartate residues at positions 2.50 and 3.49 remain likely to be the pH sensor, both of these residues 
are coordinated by positive groups. As previously described, the D2.50 is located in the Na+ ion-binding 
pocket, where its negative charge is likely to be stabilised by the Na+ ion, whilst the charged state of D3.49 
is stabilised by the salt bridge formation with Arg3.50. Of interest, these effects can also be seen in the 
Dopamine D2 receptor, where the receptor is strongly sensitive to both pH and the presence of Na+ (97). 
 
1.5.3 Ionic conditions and the Na+ effect 
 
The driving force of many physiological processes in the membrane, originate from ionic gradients across 
the aforementioned plasma membrane. Plasma membranes contain many transporters and channels, which 
have evolved to maintain strict ionic compositions on both sides of the membrane ( 
Table 1-1). Here I will not describe all the roles and effects of ion concentration, but will highlight an 
important phenomenon, which has been present in GPCRs since they evolved.  
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Component 
Intracellular 
concentration (mM) 
Extracellular 
concentration (mM) 
Na+  5-15 145.0 
K+ 140 5.0 
Mg2+ 0.5  1-2 
Ca2+  10-4  1-2 
H+ pH 7.2 pH 7.4 
Cl-  5-15 110.0 
 
Table 1-1: Ion concentrations within cells 
Comparison of ion concentrations between the intracellular and extracellular solutions. 
 
Almost half a century ago, a striking effect was reported for the opioid receptors (98). The concentration 
of Na+ was shown to negatively modulate agonist binding to opioid receptors without significantly 
modulating antagonist binding. This was termed the “sodium effect” and was used as a biochemical assay 
to differentiate agonist and antagonistic drugs in opioid receptors (99). Since then, many receptors classes 
have displayed similar biochemical properties; histamine, dopamine, adrenergic, opioid and neuropeptide 
receptors etc. (68, 100). Prior to the structural information on the Na+ binding site, Na+ was shown to bind 
to D2.50 by mutational studies of the Na+ binding pocket. However, these mutations severely disrupt the 
signalling of the receptor, though are still able to retain their agonist binding properties (65, 75). The 
allosteric effects triggered by Na+ have been described at physiological concentrations (~10 – 140 mM) 
suggesting a biological role (101, 102). The Na+ concentration can significantly affect the constitutive 
activity of receptors, in a similar manner to point mutations within the Na+ binding pocket (103–105). These 
published results support the notion that the Na+ ion stabilises the inactive state of the receptor. 
 
Though contradictory in their reported functional effects, all mono and divalent cations as well as anions 
have been shown to modulate GPCR signalling to varying degrees (100, 106, 107). The variability of results 
arises initially from the intention to optimise the experimental conditions, by the use of purified cell 
membranes (98, 102, 107). The functional studies on GPCR ion allostery, are therefore highly 
heterogeneous in terms of receptor types, membrane composition, parameters and consequently the results 
obtained, especially the order of efficacy (100, 101).  
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1.5.4 Transmembrane voltage 
 
The resting potential of the cell is governed by the concentration gradients of multiple ionic species such 
as Κ+, Na+ and Cl-, maintained by an array of ATP driven ion pumps. The movement of each ionic species 
down its chemical gradient through its respective ion channels will generate a charge imbalance across the 
membrane, thereby shifting the membrane potential to the equilibrium potential of that ion. The equilibrium 
potential is the point at which there is no net flow through any open channels. Where the opposing electrical 
and chemical gradients are at equilibrium, for each ionic species this can be calculated using the Nernst 
equation (Eq. 1-1). 
 
 
𝑉𝑒𝑞 =
𝑅𝑇
𝑧𝐹
𝑙𝑛 (
[𝑋]𝑜𝑢𝑡
[𝑋]𝑖𝑛
) 
 
[1-1] 
 
Where Veq is the equilibrium potential, R is the universal gas constant, T is temperature (Κ), z is the valence 
of the ionic species, F is Faraday’s constant, [X]out is the concentration of ionic species in the extracellular 
solution and [X]in is the concentration of ionic species in the intracellular solution.    
 
Therefore, the movement of each of the aforementioned ions through the membrane will contribute to the 
membrane potential. However, the membrane potential is also determined by the permeability of the 
membrane to each ion. The permeability of each ion is directly proportional to the total number of open 
channels for that particular ion, therefore the membrane potential can be calculated using the Goldman-
Hodgkin-Katz equation (Eq. 1-2).  
 
 
𝑉𝑚 =
𝑅𝑇
𝐹
𝑙𝑛 (
𝑃𝑘[𝐾]𝑜 + 𝑃𝑁𝑎[𝑁𝑎]𝑜 + 𝑃𝐶𝑙[𝐶𝑙]𝑖
𝑃𝑘[𝐾]𝑖 + 𝑃𝑁𝑎[𝑁𝑎]𝑖 + 𝑃𝐶𝑙[𝐶𝑙]𝑜
) [1-2] 
 
Where Vm is the membrane potential, R is the universal gas constant, T is temperature (Κ), F is Faraday’s 
constant, Pκ is the membrane permeability of Κ+ (permeability of ions are relative to Pκ), PNa is the relative 
membrane permeability of Na+, PCl is the relative membrane permeability of Cl-, [X]o is the concentration 
of ionic species in the extracellular solution and [X]i is the concentration of ionic species in the intracellular 
solution. 
 
The electrochemical driving forces (VDF) of each ionic species is quantified by the difference between the 
membrane potential and the equilibrium potential (VDF = Vm – Veq). Therefore, if Na+ has a Veq of 60 mV 
and the cell has a Vm of -70 mV, the VDF of Na+ is -130 mV, giving rise Na+ influx into the cell. In contrast, 
the Veq of Κ+ is ~ -96 mV, giving rise to a VDF of ~26 mV, leading to K+ efflux. 
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Figure 1-15: Electrical and chemical gradients across a cell membrane 
The constituents in a simplified electrochemical gradient: electrical and Na+ concentration gradient. (Left) 
Displays the electrical gradient from positively charged extracellular surface to the negatively charged 
intracellular surface of the membrane. The approximate strength of the electric field is 108 Vm-1. (Right) 
Displays the concentration gradient of Na+ from ~140mM in the extracellular to the low 5mM intracellular 
concentration. In this particular case both the Na+ concentration gradient and the Vm act synergistically. 
However, they can oppose each other, as is the case of K+ concentration gradient and Vm.        
 
The hydrophobic core of the lipid bilayer acts as the dielectric of the capacitor, separating the charge 
differences and thereby yielding the membrane potential (Eq. 1-3). 
 
 
𝑉𝑚 =  
Δq
𝐶
 [1-3] 
 
The transmembrane ion gradients generate the Vm by leading to a small charge imbalance (Δq) across the 
lipid bilayer (capacitor), which has a specific capacitance (C)  
 
Since the membrane core is extremely thin (20-30 Å), Vm is translated into an intense electric field of up to 
~108 Vm-1. Many proteins can sense this electric field and use it to regulate their function, such as ion 
channels during action potentials. As all proteins contain charged residues, it is simple to imagine how 
these charges can be reorganised, inducing a conformational change in response to the Vm. The portion of 
the protein that is sensitive to changes in the Vm is called a voltage sensor. The movement of the voltage 
sensor charges induces a transient current (gating current), which can be measured both computationally 
and experimentally, thereby providing direct information on the conformational changes induced (see 
below). 
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As previously mentioned the membrane electric field is often sensed through the translocation of charges. 
The predominant method of voltage sensing, is with charged residues and elicit gating currents, for example 
the shaker potassium channel Kv1.2 (108). Of note, changes in electric fields can also move free ions (109), 
and modulate the pKa of charged residues and lead to changes of the protonation state, which would also 
be able to initiate conformational changes.  
 
Many transporters, ion channels and receptors conformationally respond to changes in the Vm. As all 
membrane bound proteins exist within a strong electric field of up to ~108 Vm-1, any charge (Qg) within the 
TM region of these proteins are therefore moving within an electric field and will produce an electric current 
(Figure 1-16, Figure 1-17). To maintain continuity, the charges in both the intra and extracellular solutions 
also move in proportion to the total amount of charge moving within the membrane, thereby generating a 
current that is measurable in the external circuit (Figure 1-16). The most common experimental method of 
measuring gating charges is via the cut open oocyte (xenopus) technique (Figure 1-17)(110). The movement 
of a gating charge is a direct electrical marker of any conformational change within most membrane proteins 
(for review see reference 111). 
 
 
Figure 1-16: What is a gating charge? 
In the above example a membrane and protein are immersed between two solutions (internal and external), 
which connected by electrodes via the voltage clamp (battery). Here, the membrane protein contains 2 
positive charges (blue circles), and negative counter ions (red circles) in the internal solution (A). On the 
reversal of the Vm (Β) the proteins positive charges move from the internal surface to the external surface. 
In order to keep the Vm constant, the voltage-clamp circuit removes 2 negative charges (dashed circles) 
from the internal membrane solution and adds 2 negative charges to the external membrane solution. The 
recorded current upon the voltage switch therefore reflects the movement of 2 positive charges moving 
from the internal solution towards the external solution. However, if the 2 charges only move halfway 
across the electric field (transmembrane domain), then only 1 external counter ion will move. In the terms 
of the current, the charge transferred is the product of the total charge moved times the fraction of the 
electric field. Using the aforementioned example: the total charge (2) * by the fraction of electric field (0.5) 
= the gating charge (1). Figure adapted from (111).        
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As described above, gating charges are able to provide a direct measurement of the movement of charges 
in membrane proteins influenced by the Vm. It is possible to quantify gating charges either computationally 
or experimentally. The advantages of using a computational approach allows us to be able to look at one 
protein at a time, easily mutate and change parameters of specific residues though are limited by simulation 
time and the high Vm used. In contrast, the majority of electrophysiology experiments use membrane 
patches with an estimated number of proteins, and they rely heavily on an estimation of the number of 
receptors in the patch area. Therefore, the measurements can vary widely between groups (Table 3-1). The 
advantage of the experimental methodology is the use of native membranes, physiological Vm and no prior 
structural knowledge of the protein of interest. 
 
 
Figure 1-17: Experimental recordings of gating currents 
To measure gating currents, the membrane patch is subjected to a voltage step; in the case shown above, 
this is from -100 mV to 0 mV. This generates a brief spike in current (Im). This current contains both the 
gating current (Ig: red line) and the linear capacitive current (Ic: black line). Therefore to separate these 
currents, the subtracting pulse (P4) which is a voltage step that does not affect the voltage sensor, and 
therefore only generates a linear current is subtracted from the Im. Figure adapted from (111).   
 
Importantly in recent years, the conformation, function and downstream signalling of GPCRs has been 
experimentally shown to be modulated by Vm (112–117). As shown by Rinne et al (112), the Vm can either 
enhance or attenuate the transmitted agonist signal depending upon the ligand and the environment of the 
ligand binding site. The small point mutation of N6.52Q in the muscarinic receptor, can reverse the voltage 
effects of the bound ligand. However the reasons behind this switch are still unknown, the mechanism 
underpinning GPCR activation remains elusive. In addition to GPCR signalling being Vm sensitive, the 
ligand binding affinity has also shown to be voltage-dependent (117, 118).  
 
The Vm sensitivity of GPCRs may have significant physiological impact upon the cell. For example, 
neurons exhibit a shifted Vm in various regions of the brain and during development (119). Therefore the 
exact action of GPCR ligands is likely to depend upon the cellular context. In excitable cells, the 
physiological Vm during action potentials fluctuates between -90 and 50 mV, in extreme cases as 
demonstrated by hair cells in the inner ear a Vm of 150 mV can be reached (120). This could dynamically 
alter the signalling profile of each receptor and ligand by changes in the excitation state of the cell (Figure 
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1-18). For example this has been demonstrated in synaptic neurotransmission, where the kinetics of 
neurotransmitter release is reshaped on a millisecond timescale (121). Smaller long term changes in the Vm, 
such as the slow oscillations throughout its cell cycle (122). As well as distinct spatial Vm differences in 
subcompartments and substructures (123). Interestingly, a range of malignant cells types possess a more 
depolarised membrane than quiescent cell, although the medical relevance of this observation remains 
unclear (122, 124)  
 
 
Figure 1-18: The dynamic modulation of GPCR signalling in excitable cells 
(Left) An example of two ligands activating the same receptor and two distinct downstream signalling 
processes. (Right) Effects of Vm upon each ligand: upon depolarisation the signal strength induced by 
ligand 1 is attenuated whilst the signal by ligand 2 is enhanced. This potentially allows the Vm of the cell 
to dynamically modulate the signalling profile of individual ligands. Figure adapted from (125).      
 
1.6 Project aims 
 
Previous research on GPCR activation and signalling, have demonstrated that the physiological 
environmental factors such as transmembrane voltage, The Na+ effect, pH and lipid composition are strong 
allosteric modulators (see section 1.5). In 2006 it was demonstrated by Ben-chaim et al (118), that the 
modulation of Vm on the physiological range induces conformational changes within the m2 muscarinic 
receptor, giving rise to gating charges between 0.7 - 0.85 e. Since then gating charges in the range of 0.5 - 
0.85 have been recorded in several members of the Rhodopsin GPCR family: m1, m2 muscarinic receptors 
and the α2A adrenergic receptor (112, 113, 118, 126). Despite these measurements, the nature and location 
of the voltage sensor has remained elusive, therefore eluding to a more complex voltage sensor composed 
of multiple components.  
 
The initial aims of this project were to understand the effects of Vm changes upon the receptor. This was 
achieved by looking at the structural and consequences of Vm upon two GPCRs via atomistic molecular 
dynamics (MD). I first chose to investigate the δ-Opioid receptor, due to the availability of a high quality 
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crystal structure, its clinical importance and its exclusive distribution within the central nervous system 
(CNS), where it is frequently exposed to rapid and extreme changes to Vm. In addition, I included the m2 
muscarinic receptor, on which the majority of experimental measurements of charge rearrangements were 
performed (118, 126).         
 
Since the crystallisation of the A2A adenosine, β1 adrenergic, protease-activated and δ-Opioid receptors 
revealing a Na+/water cluster within the core of transmembrane bundle (Figure 1-14)(64–67). It has become 
established that the inactive Rhodopsin GPCR family structures contain a Na+ bound within the ion binding 
pocket. However, interestingly, subsequent crystal structures of Rhodopsin GPCRs in an active state show 
a collapsed Na+ ion binding site (20, 74, 127–131), prompting the question of what happens to the Na+ ion 
upon activation, how does it leave the receptor and what are the consequences? 
 
Therefore, using a combination of computational techniques on the m2 muscarinic receptor. I will 
investigate the position of the Na+ ion and any subsequent changes in receptor conformation upon receptor 
activation. The M2R will be simulated under physiological conditions using the CompEL approach, 
allowing the inclusion of ion gradients and transmembrane voltage.  
 
Small mutations in the Rhodopsin family of GPCRs can drastically alter GPCR signalling profiles from β-
arrestin to G-protein and vice versa. In the paper published by Fenalti et al (65), they presented a single 
residue mutation at position 3.35 in the δ-OR, one of the least conserved residues within the Na+ binding 
site. This mutation to either a valine or alanine resulted in a significantly reduced or abolished Na+ binding. 
These mutations also had a major impact upon the signalling pattern of the receptor, resulting in a 
constitutively active receptor in the β-arrestin biased pathway.  
 
To investigate the effects of the N1313.35 δ-OR mutants, I will use microsecond length simulations to study 
any conformational changes within the receptor. Additionally, I will examine the effects of the protonation 
states of D952.50 and D1453.49 upon the receptor conformation.  
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Chapter 2. Theory and simulation setup 
 
2.1 Theory 
 
 
It has been more than 40 years since the first Molecular Dynamics (MD) simulation of a macromolecule 
with a biological interest has been published (132). The original simulations were less than 10 ps in length, 
to compare; simulations now easily access the microsecond range, however with the availability of 
resources such as the Anton supercomputer, simulations can reach the millisecond range. However, much 
of the improvements in MD simulations are reinvested back into studying much larger and more complex 
systems of large protein complexes. In the subsequent sections, I will explain specialised state-of-the-art 
MD techniques, which are pertinent to the following chapters, such as: computational electrophysiology, 
gating charge calculations and umbrella sampling (for in depth information see (133)).      
 
Proteins typically consist of between ten to hundreds of amino acids, this amounts to several thousand 
atoms for the protein alone. The dynamics of the proteins include bond vibrations at the femtosecond 
timescale to conformational changes of protein domains at the mico- to milli-second timescale. To date, 
the best computational method that can accurately describe the molecular dynamics of proteins and access 
physiologically relevant timescales is Molecular Dynamics (MD) simulations. 
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2.1.1 The core concepts of molecular dynamics 
 
The classical forcefields in MD simulations allow for the calculation of the potential energy of a system, 
as a function of the nuclear position of each atom. Under the Born-Oppenheimer approximation, the 
motions of the atomic nuclei and electrons can be treated independently.   
 
 
Figure 2-1: The molecular dynamics force field 
A schematic representation of the five key elements which compose empirical molecular dynamics 
forcefields. (Top) The three bonded interactions comprise terms for bonded interactions: Ubonds, Uangles and 
Utorsions. (Bottom) The two non-bonded interactions comprise of electrostatic modelled by a Coulomb 
potential (UCoul) and the Van der Waals modelled by a Lennard-Jones potential(ULJ). 
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Where U denotes the potential energy which is the function of the vector (r) of N particles (rN = r1, r2, …, 
rN). The force field parameters for the bonded interactions; bond length and angles are described as a 
harmonic potential around their reference value 𝑙𝑖,0  and 𝜃𝑖,0 , respectively, with their respective force 
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constants ki. The third bonded interaction is described by a torsional potential around the dihedral angle 
with a multiplicity of n, 𝐾𝑖  is the torsional barrier height and 𝛾𝑖  is the phase of the dihedral. The 
electrostatics interactions are treated using Coulomb’s law describing the interactions between the partial 
charges 𝑞𝑖 and 𝑞𝑗 on their respective atoms, separated by the distance 𝑟𝑖𝑗 , 𝜀𝑟 is the relative permittivity of 
the medium included within the non-bonded term, which is given by the permittivity of the substance 𝜀𝑠 in 
relation to the absolute permittivity of a vacuum 𝜀0. The van der Waals (vdW) interactions can be treated 
using the 12-6 Lennard-Jones potential, where the repulsive interactions arising from the overlap of the 
electron cloud can be treated as (𝜎𝑖𝑗/𝑟𝑖𝑗)
12
 whilst the attractive interactions arising from the dispersive 
forces are treated by (𝜎𝑖𝑗/𝑟𝑖𝑗)
6
. The width (finite distance at which the inter-particle potential is zero) is 
described by 𝜎𝑖𝑗  and depth of the Lennard-Jones potential by the 𝜀𝑖𝑗. The Lennard-Jones potential provides 
a computationally efficient approach to modelling the vdWs interaction as the 𝑟12  term can be computed as 
the square of the 𝑟6 term.   
 
The non-bonded interactions are the most computationally expensive part of the force calculations. A 
simple way of enhancing the calculation efficiency is by applying a cut off to the non-bonded interactions, 
this is typically in the range of 10-14 Å, though throughout this work an intermediate cutoff of 12 Å was 
chosen. This cutoff works well with the rapidly decaying Lennard-Jones potential, however produces errors 
when applied to the Coulomb potential (134). Therefore, a Particle Mesh Ewald sum (PME) for the 
electrostatic interactions is implemented within the simulations, which separates the electrostatics into short 
and long range interactions. The short range interactions are calculated directly whilst the long range are 
calculated in reciprocal space (135). 
 
MD forcefields developed varying strategies to parameterise the above terms. Throughout this thesis, I will 
use the amber99sb-ildn force field (136). The amber99sb-ildn is one of the most commonly used forcefields 
from the amber package, updated in 2010 from the original amber forcefield amber99sb in which it was 
found to over stabilise α-helices (137). The backbone dihedrals for isoleucine, leucine, aspartate and 
asparagine were updated to correct for this (136). The amber99sb-ildn forcefield has been developed for 
both proteins and nucleic acids, therefore the non-protein/nucleic portions of the system require additional 
parameters.  
 
Throughout my simulations, I used updated Berger lipid parameters which were parameterised using a 
united atom approach, in which the non-polar hydrogens are unified with the carbon they are bound to (138, 
139). The resulting CH, CH2 and CH3 groups are treated then as a united atom, which has been adjusted 
for the correct Lennard-Jones parameters, mass and charge. Explicit water molecules were used throughout 
this thesis, the SPCE water model (140) was used in Chapter 3, whilst TIP3P (141) was used in Chapters 4 
and 5 due to the increased diffusion coefficient accuracy. In both cases the water bond angles and distances 
were constrained by SETTLE (142). 
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The nuclear dynamics in MD simulations are described by Newton’s second law (Eq. 2-2).  
 
 
−
𝜕𝑈
𝜕𝒓𝑖
=  𝑭𝑖 =  𝑚𝑖𝒂𝑖 =  𝑚𝑖
𝑑𝒗𝑖
𝑑𝑡
 =  𝑚𝑖
𝑑2𝒓𝑖
𝑑𝑡2
 [2-2] 
 
The negative gradient of the potential energy (U) is the force (Fi) acting on an atom at position 𝒓𝑖. Where 
𝑚𝑖 is the atomic mass, 𝒂𝑖 is acceleration, 𝒗𝑖 is the velocity. The forces on each atom over a given timestep 
(𝑑𝑡) are assumed to be constant. Therefore, after each timestep the new atomic coordinates and forces are 
updated iteratively, over the desired MD trajectory length.   
 
Newton’s equations of motion are integrated with the Verlet leapfrog algorithm, where the integration 
timestep is generally chosen to be smaller than the fastest motion of the system. The bond vibrations 
involving hydrogen occur on the femtosecond timescale, preventing the timestep from exceeding 1fs, 
however, throughout this thesis I include the LINCS algorithm which allows for greater timesteps to be 
chosen (143). Despite using the LINCS algorithm, the time step is still limited by the high-frequency bond-
angle vibrations involving hydrogen atoms. The removal of these degrees of freedom from the system by 
constructing certain hydrogen atoms as dummy atoms (termed virtual sites) such as methyl groups, allowing 
the time step to be increased to 4 fs (144). 
The microscopic behaviour of the MD simulations described here, can be linked to the experimentally 
measured macroscopic properties, such as pressure and energy by statistical mechanics. In MD simulations 
a statistical ensemble is obtained by the evolution of the system over time (MD trajectory), from which 
macroscopic properties can be taken as time averages. According to the ergodic hypothesis, the resulting 
time average is equal to the ensemble average observed in experiments (Eq. 2-3). 
 〈𝐴〉𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 =  〈𝐴〉𝑡𝑖𝑚𝑒 
𝐸𝑛𝑠𝑒𝑚𝑏𝑙𝑒 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 = 𝑇𝑖𝑚𝑒 𝑎𝑣𝑒𝑟𝑎𝑔𝑒  
[2-3] 
 
For a realistic simulation of a protein it must be as close to in vivo as possible. For a membrane bound 
protein, a lipid bilayer, water and ions (NaCl) are added to the system. However, the addition of these 
solvating molecules within a finite system box generates large artifacts, such as boundary artifacts. Here, 
this is solved by using periodic boundary conditions (PBC) in which the system is modelled as an infinitely 
replicating box. The PBC removes errors generated from artificial boundaries, however care must be taken 
not to choose a too small box in which the particles can interact with each other. 
 
Due to approximations when calculating the non-bonded interactions, the potential energy of the system 
fluctuates. Therefore, the simulation temperature T is adjusted to compensate, the systems temperature is 
coupled to a heat bath by the v-rescale method with a reference temperature of T0 (310 Κ) with the coupling 
constant of τT 0.2 ps (145). The simulation system is grouped in its main constituents; protein and lipids, 
whilst the water and ions are combined into one group. The separation of the system into its main 
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constituents increases the accuracy of the simulation temperature, as the bulk solvent contains a higher 
number of interactions and therefore undergoes a higher degree of thermal fluctuation in comparison to the 
protein and lipids. The temperature coupling assumes that the system is at thermal equilibrium, therefore 
the aforementioned groups are treated individually, consequently removes any differences between the 
main constituents.  
 
2.1.2 Computational electrophysiology (CompEL) 
 
The use of PBC, which are required to remove surface effect artifacts, prevents the generation of 
electrochemical gradients across a single bilayer system (Figure 2-2 A). For the CompEL setup, a single 
bilayer is therefore duplicated along the z axis, thereby forming two discrete aqueous compartments (Figure 
2-2: black and blue squares) (as previously described in (146, 147)). Under physiological conditions the 
lipid bilayer is impermeable to water and ions, which allows the conditions for each compartment to be 
distinct from each other. In this way, the ion type and concentration, pH, osmotic pressure and electric 
charge in each compartment can be altered independently according to the aim of the study. Upon the 
insertion of a channel within the membrane rendering the membrane permeable. The CompEL protocol 
implemented within GROMACS monitors the number of ions within each compartment. If an ion moves 
from one compartment to another, creating a mismatch from the chosen concentration, an ion is swapped 
with a water molecule in the other compartment until the mismatch is corrected.  
 
To generate a transmembrane potential, a charge imbalance (Δq) between the aqueous compartments is 
required (Figure 2-2 B). If a single ion with a charge of 1e is moved from compartment A to compartment 
Β, this generates a Δq of 2e in the convention used by CompEL, therefore by using the capacitance 
(1.28x10-18 F) of the membrane and protein in this particular system, we obtain a Vm of ~250mV per ion 
exchange in agreement with equation 1-3. In spite of the internal charge imbalance within the system, the 
total charge of the double bilayer system remains zero. The perturbations arising from the ion-water 
exchange are minimised by only selecting molecules which fulfill a certain distance criterion from the 
membrane boundary, and therefore from the protein of interest.  
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Figure 2-2: Single bilayer and dual bilayer (CompEL) setup 
(A) Left: a standard single bilayer system (~92 x 88 x 97 Å3) containing a membrane bound GPCR with 
the two compartments connected by periodic boundary conditions (PBC). Right: No potential difference 
exists between the intracellular and extracellular sides of the lipid bilayer. The potentials are continuous 
due to the periodic boundary conditions (Β) Left: Example of the dual bilayer approach, with compartment 
A and Β (blue and black squares, respectively) delimited by the impermeable lipid bilayer. Right: Shows 
an example of the potential between compartments, with the application of a single ion imbalance, 
generating a Vm of ~250mV.  
 
2.1.3 Deriving the gating charge 
 
There are three main methods to determine gating charges computationally: the first evaluates the 
dependence of the local electrostatic potential on the Vm, this approach requires the calculation of the 
electrostatic potential over three dimensions and the convergence of the local potential (148). The second 
is the use of perturbative free energy calculations to determine the contributions to the Qg via the charging 
free energy of chosen amino acids (149). The aforementioned methods are computationally expensive and 
are difficult to apply to a large range of residues and cannot encompass all movements involved in voltage 
sensitivity.  Throughout the thesis, I used a method derived from computational electrophysiology (see 
above), enabling both accurate estimates and mechanistic insight into the contributions of charges to the 
Qg. This method is based upon the simulation of the membrane protein capacitor charging process, 
originally developed by Treptow et al (150), allowing the direct determination of the Qg, and any change 
in capacitance resulting from most components of the voltage sensitivity (Figure 2-3)(151).    
 
38 
 
Figure 2-3: Gating charge recordings 
(A) Left: Example of the inverted bilayer approach, with compartment A and Β (blue and black squares, 
respectively) delimited by the impermeable lipid bilayer. Right: Example Potential between compartments 
calculated along the z-axis. Each ion imbalance generates a Potential imbalance of ~250mV (Figure 2-2). 
(B) An example of the membrane voltage plotted against charge imbalance, exhibiting a linear relationship. 
The slope of the curves denotes the inverse capacitance of the system, which is nearly identical for the two 
Na+ ion positions. The voltage can display either a right of left shift depending on the direction of ion 
movement, the example shown here displays the effect of the ion movement from the allosteric binding 
pocket to the transient binding site within the orthosteric ligand binding site. Error bars are the standard 
deviation of the voltage fluctuation. (C) Shows the minimum and maximum capacitances derived from the 
lowest and highest Vm and vice versa measured in the M2R. This gives the error in the capacitance 
determination.  
 
The use of an adapted CompEL system is required for determining gating charges. In contrast to the 
standard CompEL, one of the protein/membrane groups are inverted. Therefore, the intracellular and 
extracellular domains of the receptor face each other, respectively. In this inverted setup, the charge 
distributions of the proteins do not cancel each other out, but are additive to one another. Therefore, in most 
cases the charge imbalance arising between the compartments purely due to the distribution of charges in 
the proteins is neutralised by adding ions (NaCl). The inverted double system also has the benefit of 
doubling the signal to noise ratio. The signal noise of 10-30mV arises from the association and dissociation 
of the bulk solution ions to the membrane. 
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An initial charge titration of the system is conducted, which provides the capacitance (C) of the system. In 
the case of proteins with deep hydrophilic pockets low position restraints in the z direction upon the ions 
in the bulk solvent can be applied to prevent ingress. In the example shown above (Figure 2-3 B), the charge 
imbalance and Vm have a linear relationship, with any charge movement within the membrane-giving rise 
to a left or right shift in Vm. Regardless of the charge movement within the receptor the capacitance of the 
system remains constant. The gating charge (Qg) can therefore be calculated by equation 2-4. 
                       
 
𝑄𝑔 =
Δ𝑉𝑚(𝑖,𝑗)𝐶
4
 [2-4] 
 
During the calibration of the system (Figure 2-3 B), the slope of the relationship refers to the inverse 
capacitance (C) of the membrane and protein. Once the capacitance of the system is known, the Vm 
difference between each conformational state (Vm(i,j)) at a given charge imbalance allows the 
determination of the gating charge (Qg). Due to the CompEL convention, the movement of a single charge 
from the intracellular to the extracellular induces a charge imbalance of q of 2 e. Additionally, the inverted 
protein/membrane system doubles the calculated gating charge, therefore the gating charge must be halved.  
   
 
Qerr =
𝑉𝑚(𝑖)𝐶𝑚𝑖𝑛 − 𝑉𝑚(𝑖)𝐶𝑚𝑎𝑥
8
 [2-5] 
 
Equation 2-5 describes the error estimation for the gating charge calculation. The error (Qerr) is derived 
from the minimum and maximum possible capacitances of the system, Cmin and Cmax, respectively (Figure 
2-3 C). Throughout the remaining chapters, all errors involving the CompEl derived gating charges are 
denoted with ± Qerr. 
 
2.1.4 Umbrella sampling and potential of mean force 
 
To calculate the potential of mean force along a specific reaction coordinate, a technique called umbrella 
sampling is typically used. This technique aims to overcome sampling problems arising from energetically 
unfavourable conditions by restraining specific subsections of the simulation by an additional potential 
(harmonic potential, equation 2-6).  
 
 
𝑤𝑖(𝜉) =  
𝐾𝑖
2
(𝜉 − 𝜉𝑖
𝑐)2 [2-6] 
 
A set of simulations (umbrella windows) are carried along the reaction coordinate which are restrained at 
the position 𝜉𝑖
𝑐(𝑖 = 1, … , 𝑁𝑤) by an umbrella potential with a force constant of 𝐾𝑖 . From each simulation 
an umbrella histogram is extracted ℎ𝑖(𝜉), which represents the probability distribution 𝑃𝑖
𝑏(𝜉) along the 
previously described reaction coordinate which is biased by the umbrella potential 𝑤𝑖(𝜉) (Eq. 2-7). One of 
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the widely used methods to unbias the probability distributions is the weighted histogram analysis method 
(WHAM).  
 
 
𝑃(𝜉) =  
∑ 𝑔𝑖
−1ℎ𝑖(𝜉)
𝑁𝑤
𝑖=1
∑ 𝑛𝑗𝑔𝑗
−1exp [−𝛽(𝑤𝑗(𝜉) − 𝑓𝑖)]
𝑁𝑤
𝑗=1
 [2-7] 
 
 
exp(−𝛽𝑓𝑖) =  ∫ 𝑑𝜉 exp[ −𝛽𝑤𝑗(𝜉)]𝑃(𝜉) [2-8] 
 
The 𝛽 denotes the inverse temperature 1/𝑘𝐵𝑇, with the Boltzmann constant 𝑘𝐵 and the temperature 𝑇, 𝑛𝑗 
is the number of data points in the histogram ℎ𝑗. The statistical inefficiency 𝑔𝑖 is given by 𝑔𝑖 = 1 + 2𝜏𝑖, 
with the integrated autocorrelation time of 𝜏𝑖  of umbrella window 𝑖 . The 𝑃(𝜉)  denotes the unbiased 
probability distribution related to the PMF by equation 2-9, the 𝜉0 is the reference point where 𝑊(𝜉0) is 
set to zero. The WHAM equations 2-7 and 2-8 contain the free energy constant 𝑓𝑖  and the unbiased 
distribution 𝑃(𝜉) which must be solved iteratively. For the derivations of the equations see reference (152) 
 
 
𝑊(𝜉) =  −𝛽−1ln [
𝑃(𝜉)
𝑃(𝜉0)
] [2-9] 
 
2.2 Methods 
2.2.1 Receptor preparation 
 
Throughout the following chapters I will concentrate upon 2 GPCRs, namely the δ-Opioid (δ-OR) and the 
m2 muscarinic receptors (M2R). The δ-OR and M2R simulation systems were constructed using the 
inactive state crystal structures (PDB: 4N6H and 3UON, respectively (65, 153)). Extraneous subunits added 
to the receptor to aid in the crystallisation process were removed. However, as is common in the 
crystallisation of GPCRs, this subunit was inserted in place of the intracellular loop 3 (ICL 3) in the M2R, 
I therefore reconnected the cleaved ICL 3 loop using Modeller v9.14 (154). In both systems, all external 
water and lipid molecules were removed, whilst all internal molecules were retained (except for the 
antagonists). After all extraneous material was removed, the charged N- and C- termini were neutralised 
using acetyl and methyl moieties, respectively. The receptors were simulated with default protonation 
states, including a negatively charged D3.49 and D2.50 unless otherwise mentioned. The δ-OR mutants 
N1313.35V and N1313.35A used in Chapters 3 and 5 were generated from the previously described δ-OR 
system.  
 
To study the active state of the M2R in Chapter 4, I used a different approach to generate the system: I first 
parameterised the agonist carbachol using the AMBER16 software suite, GAFF2 atom types and the AM1-
BCC charge model (155). The agonist carbachol was then docked into the orthosteric ligand-binding site 
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of the previously described inactive M2R using GOLD (v5.2.2). As I wished to study the role of Na+ in the 
active M2R a Na+ ion was placed within the Na+ binding site in the inactive M2R structure. A targeted MD 
approach using the RMSD of the active receptor backbone (PDB: 4MQT (131)) as a reference. To enforce 
the transition from the inactive (PDB: 3UON) to the active state, position restraints of 50 kJ mol-1 nm-2 were 
applied to the Cα atoms within the transmembrane domain, this system was then further equilibrated for a 
total of ~250 ns. To help keep the receptor in an active conformation despite the absence of G-protein, I 
applied a minimal set of four distance restraints to the Cα atoms of the terminal groups of TM helices 2,5,6 
and 7, namely residues 2.39-6.33, 2.39-5.61, 2.43-7.54 and 6.36-7.54, at this interaction site (Figure 2-4). 
In the active M2R simulations, two major conformations of Y4407.53 were observed during the simulation. 
These were probed systematically in the PMF calculations using distance restraints between N1.50-Cα and 
D2.50-Cα to Y7.53-Cζ or dihedral restraints on the sidechain of Y7.53. 
 
 
Figure 2-4: Minimal set of distance restraints used to maintain the active conformation of the M2R 
A set of four distance restraints (shown by red bars) was applied to the intracellular portion of the 
transmembrane helices as described above. This procedure serves to maintain the M2R in an active state 
despite the absence of a bound G-protein. With bound Na+ at the negatively charged D2.50, the receptor 
regains its inactive conformation on time-scales below microseconds in most simulations without these 
restraints, which is agreement with the role of sodium as stabilizer of the inactive conformation. Figure 
adapted from (156). 
 
2.2.2 Simulation setup 
 
Each of the aforementioned receptors was inserted into a fully equilibrated and hydrated 1,2-palmitoyl-
oleoyl-sn-glycero-3-phosphocholine (POPC) lipid bilayer using the GROMACS utility g_membed (157). 
The single bilayer simulation box is approximately ~92 x 88 x 97 Å3. A NaCl concentration of 145 mM 
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was used in the aqueous solution in the single bilayer systems. For the initial equilibration, all protein heavy 
atoms were position restrained with a force constant of 1,000 kJ mol-1 nm-2 was applied for 5-10 ns. In 
contrast to the δ-OR crystal structure, the M2R crystal structure was resolved at a much lower resolution 
and showed minimal hydration. Therefore the system was equilibrated for a further 100 ns without restraints 
to enable full hydration.  
 
2.2.3 CompEL setup 
 
For the CompEL simulations, the aforementioned systems (see section 2.2.1) were duplicated along the z-
axis to create a double membrane system. Charge imbalances of between one and four were used between 
aqueous compartments, generating a range of Vm from ~0 to 1,000 mV. For a 100x100x200 Å simulation 
box, a Vm of 250 mV was generated per each charge imbalance. The slightly supra-physiological Vm was 
used in order to accelerate voltage-induced effects to a computational timescale. The Vm was determined 
using the GROMACS utility g_potential using overlapping 2 ns windows with a 1 ns running average 
throughout the trajectories. For the work in Chapter 3 and 5, I used symmetric NaCl concentration in both 
compartments of 145 mM. For the work in Chapter 4, I included a physiologically relevant NaCl gradient 
of 150 mM: 10 mM between the extracellular and intracellular compartments.  
 
2.2.4 Gating charge 
 
I throughout this work, the focus was on the gating charge arising from cation movement from the allosteric 
binding pocket (ABS) and the bulk solution, therefore to minimise signal noise arising from the protein, 
position restraints of 1000 kJ mol-1 nm-2 were applied to the heavy atoms. 
 
To scan Na+ ion position effects upon the gating charges within the δ-OR and M2R, the Na+ ion was 
restrained at 2.5 Å intervals along the z-axis from the ABS to the extracellular or intracellular bulk solution. 
Each position was simulated for 50ns with the first 5 ns discarded. For the M2R the Na+ ion was positioned 
in the ABS identically to the δ-OR, coordinated by D2.50 and S3.39. Whilst for the wt δ-OR system, the 
positional restraints for the residue N1313.35 was removed due to clashes with the Na+ ion. The gating 
charges arising from the protonation state changes of D692.50, D1033.32 and the extracellular bulk solution 
(D173ECL2) within the M2R, were undertaken in a similar manner as with the Na+ ion movement. The Vm 
was determined at each protonation state and the gating charge difference was calculated as per equation 
3. For the calculation gating charges arising from the conformational change of the M2R transitioning from 
the inactive to active, I used the same protocol whereupon the Vm was determined for the inactive (PDB: 
3UON (153)) and active crystal structure (PDB: 4MQT (131)). The system was equilibrated for 30ns before 
calculating the gating charge arising from the conformational change.  
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2.2.5 Forcefield parameters 
 
For all simulations, the amber99sb_ildn force field was used for the protein (136), Berger parameters for 
lipids (138), which were adapted for use with the amber99sb force field (139), and the SPC/E or TIP3P 
model for water molecules (140). Water bond angles and distances were constrained by SETTLE (142) 
while all other bonds were constrained using the LINCS method (143). The temperature and pressure were 
kept constant throughout the simulations at 310 K and 1 bar, respectively, with the protein, lipids, and 
water/ions coupled individually to a temperature bath by the v-rescale method using a time constant of 0.2 
ps and a semi-isotropic Berendsen barostat (145, 158). Employing a virtual site model for hydrogen atoms 
(144) allowed the use of 4-fs time steps during the simulation. All simulations were performed with the 
GROMACS software package, Chapter 3: Version 4.6 (159), Chapter 4 and 5: version 5.1.2 (160).   
 
2.2.6 Potential of Mean Force 
 
To calculate the potential of mean force (PMFs) in Chapter 3 for the movement of the Na+ ion within the 
ABS through to the orthosteric pocket at neutral Vm, umbrella sampling was utilised in conjunction with 
the GROMACS utility g_wham (161). Bins of < 0.5 Å were used with simulation time of >150ns for each 
umbrella window. To record the PMF of ion movement within the pocket of the M2R, the system was first 
simulated under a hyperpolarised Vm until a Na+ ion had relocated to the ABS.  The error bars of the PMF 
profiles was were derived by using the Bayesian bootstrap method with 200 runs. The free energy minima 
of the Na+ ion within the wt, N1313.35V δ-OR and M2R were set to G = 0 kJmol-1. Throughout Chapter 3, 
the position of the Na+ ion (z-coordinate) is reported relative to the D2.50-Cα atom of the respective receptor.       
 
To calculate the PMFs in Chapter 4 for the movement of the Na+ ion within the hydrophilic pocket through 
to the intracellular solution at neutral Vm, umbrella sampling calculations were performed in bins of 0.25Å 
and analysed with the GROMACS utility gmx wham. I used a simulation time of 50ns in each window and 
harmonic potentials of 900–2000 kJ mol-1 nm-2 to restrain the Na+ ion in the z-direction. The standard 
deviation of the PMF profiles was estimated by using the Bayesian bootstrap method, as implemented in 
gmx wham, with 200 runs. The free energy of the Na+ ion in bulk solution was set to 0. The position of the 
Na+ ion (Z-coordinate) is reported relative to the D1033.32-Cα atom (ligand binding site). 
 
To calculate the voltage induced tilt of the PMFs. The gating charges calculated for each position along the 
receptor was taken as a direct measure of the shape of the underlying voltage drop. The energy supplied by 
the voltage drop can be derived from Mitchells equation (Eq. 2-10).  
 
 
ΔG = zFV + RT𝑙𝑛 (
[𝑋]𝑜𝑢𝑡
[𝑋]𝑖𝑛
) [2-10] 
 
Where the ΔG is the free energy supplied, z is the charge of the ion species, F is Faraday’s constant, V is 
the transmembrane voltage, R is the gas constant, T is the temperature, [X]out is the concentration of ionic 
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species in the extracellular solution and [X]in is the concentration of ionic species in the intracellular 
solution. The resulting energy is multiplied by e with a linear interpretation between points, was added to 
the PMF obtained from the umbrella sampling, in order to illustrate the effects of Vm upon the energetics 
of the Na+ ion within the receptor.     
 
2.2.7 pKa calculations 
 
The pKa calculations in Chapter 4 were undertaken by Ms Catarina A. Carvalheda. These were performed 
on the basis of simulation snapshots taken at 2 ns intervals (between 10 and 20ns) from each umbrella 
windows (see section 2.2.6). The pKa calculations were performed using a continuum electrostatics method, 
namely the Poisson-Boltzmann/Monte Carlo (PB/MC) approach. PB calculations were performed using 
MEAD (version 2.2.9)(162) with a dielectric constant (εp) of 4 for the protein and 80 for the solvent (εw), 
in the presence of an explicit membrane. The temperature was set to 310 K and the ionic strength to 0.145 
M. The same temperature was used for MC calculations (103 steps in each calculation), which were 
performed using MCRP (163). Each MC step consisted of a cycle of random choices of a state for all 
individual sites and pairs of sites with couplings above 2.0 pKa units (163), whose acceptance/rejection 
followed a Metropolis criterion (164). Tautomeric forms were not included. 
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Chapter 3. Putative voltage sensor in class A GPCRs 
 
3.1  Introduction 
 
Transmembrane voltage (Vm) is a fundamental property of all membranes, generated by electrochemical ion 
gradients across semi-impermeable lipid bilayer (122). As the Vm drops across a thin hydrophobic core of 
the membrane, < 30 Å thick along the membrane normal, extremely strong electric fields of up to 107-108 
Vm-1 exist (165). Whilst extensive work has been done on the effects of Vm upon ion channels in particular 
voltage-gated ion channels, the effect of Vm upon the function of other membrane proteins has been given 
little thought. 
 
3.1.1 GPCR voltage sensitivity 
 
As discussed within Chapter one, GPCRs form the largest group of integral membrane proteins in the human 
genome (4). It has been shown that the modulation of Vm within the physiological range elicits functional 
and conformational changes in several GPCRs and families: muscarinic, dopamine, adrenoceptor, 
glutamate, 5-HT and P2Y (112–117, 166, 167). Of particular interest, voltage-induced rearrangement of 
charges (gating currents) were uncovered by electrophysiological recordings of the α2A adrenergic, m1 and 
m2 muscarinic receptors (M1R and M2R), from these experiments, evidence of a gating charge of ~0.5 - 
0.85 were obtained (Table 3-1, Figure 3-1) (112, 113, 126, 168). Most of these measurements converge to 
a gating charge of near 0.55 e (125).  
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Receptor Gating charge (e) Reporter method Ref 
m1 muscarinic:    
wt 
0.72 FRET (112) 
0.76 FRET (112) 
m2 muscarinic:    
wt 0.55 Electrophysiology (126) 
wt 0.7 Electrophysiology (118) 
wt 0.85 Electrophysiology (118) 
D692.50A Not resolved Electrophysiology (126) 
W993.28A 0.8 Electrophysiology (126) 
D1033.32A 0.5 Electrophysiology (126) 
Y1043.33A 0.54 Electrophysiology (126) 
S1073.36A 0.49 Electrophysiology (126) 
D1203.49N 0.66 Electrophysiology (118) 
D1203.49N-R1213.50N Not resolved Electrophysiology (118) 
D1203.49N-R1213.50N 0.52 Electrophysiology (126) 
Y4036.51A 0.57 Electrophysiology (126) 
α2a-Adrenergic:    
wt 0.5 Electrophysiology (113) 
 
Table 3-1: Gating charges reported for the Rhodopsin GPCR family 
This table shows all previously reported gating charges for the M1, M2 muscarinic receptor and the α2a-
Adrenergic receptor.     
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Figure 3-1: Experimental mutations of the M2R to elucidate the origin of the gating charges 
All mutated M2R residues that were listed in Table 1, probing the origin of voltage sensor are shown in 
cyan. Mutation of these residues was shown to have no effect upon the measured gating charges with the 
exception of D2.50. Water molecules are depicted as red surface and the allosteric Na+ ion as a purple sphere.  
3.1.2 Chapter overview 
 
Throughout this chapter, I will address the structural and functional consequences of Vm upon two GPCRs 
via atomistic molecular dynamics (MD) employing state of the art computational techniques. I first chose 
to investigate the δ-Opioid receptor, due to the availability of a high quality crystal structure, its clinical 
importance and its distribution within the nervous system. The δ-OR is predominantly expressed within 
neurons in the brain and in the dorsal root ganglion, where it is frequently exposed to rapid and extreme 
changes to Vm (120, 170, 171). In addition, I included the m2 muscarinic receptor, on which the majority 
of experimental measurements of charge rearrangements were performed (118, 126).      
 
Here, I will demonstrate that the allosteric Na+ ion is the most mobile charge within the TM domain of the 
Rhodopsin family, and sensitive to alterations in Vm.  The coordination pattern of the Na+ ion within the 
hydrophilic pocket depends strongly on the Vm. Additionly; the voltage induced transition of the Na+ ion 
generates a gating charge in excellent agreement with the previous experimentally obtained values. It is 
possible for other cations to bind within the hydrophilic pocket, thereby replacing the Na+ ion (100, 101). 
The large scale transitions of the receptor from inactive to active as derived from the crystal structures of 
the M2R, gives rise to gating charges far smaller than the experimental observations. The data suggests that 
the movement of a single charge from the ABS through the hydrophilic pocket is the most plausible 
mechanism to explain the experimentally obtained gating currents. 
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3.2 Results 
 
3.2.1 Voltage-induced mobility of the allosteric Na+ ion 
 
A series of atomistic simulations were conducted using the computational electrophysiology (CompEL) 
protocol (146) on the wt and mutant δ-OR with a depolarised Vm, with a total simulation time of >30 µs 
(Table 3-2). By applying a Na+ electrochemical gradient (1-4 ions) across the membrane, evoking a Vm 
between -1000 mV and 1000 mV in 250mV increments, the amplitude of the Vm enables us to accelerate 
any effects that might be missed due to the limited simulation timescale. Due to its conservation as an 
ionisable residue and its close interaction with a Na+ ion within the crystal structure, the side chain of the 
D952.50 was modeled in the negatively charged protonation state. Furthermore, I found that the protonation 
and therefore the neutralisation of the D952.50 sidechain abolished the affinity of the ABS for the Na+ ion, 
even under 0 mV, such that the ion can spontaneously dissociate in very short timescales. The protonation 
of D2.50 is therefore incompatible with the crystallographically observed Na+ ion in the inactive receptor 
conformation. 
 
Receptor 
Ion imbalance (1 ion = ~ 250mV) 
0 1 2 3 4 
δ-OR wt 3x 1x 5x 8x 4x 
δ-OR N1313.35A    2x 1x 1x 1x 1x 
δ-OR N1313.35V    2x 1x 2x 1x 1x 
δ-OR D952.50A    1x 1x — — — 
M2R wt 2x 4x 4x — 10x 
 
Table 3-2: Simulation conditions specifying the ionic imbalances and replicates. 
A complete list of simulations run, displaying the number of repeats and ionic imbalances used on the wt 
M2R, wt δ-OR and the three δ-OR mutants: N1313.35A, N1313.35V and D952.50A. Note that at each ion 
imbalance, both hyper- and depolarised receptors are simulated simultaneously (see section 2.1.2).  
 
The simulations under Vm show that the coordination of the Na+ ion in the δ-OR receptor is strongly 
influenced by the electric field. In the case of the wt δ-OR, when the depolarised Vm exceeds 700 mV the 
Na+ ion is expelled from the ABS in the core of the receptor, and moves to a conserved aspartate (D1283.32) 
within the orthosteric ligand binding site (Figure 3-2 A, Β). At this site, the Na+ ion is coordinated by the 
side chains of D1283.32, N1313.35, and the backbone of D1283.32; this binding site is extended further towards 
the orthosteric site, where the Na+ ion predominantly coordinates with the side chain oxygen atoms of 
D1283.32. From this transient binding site (TBS), the Na+ ion can either leave the receptor completely and 
enter the extracellular space, or reenter the ABS. Within simulations under neutral or negative Vm, no 
movement of the Na+ ion to the extracellular space is recorded (Figure 3-3).  
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In experiments undertaken by Fenalti et al, the δ-OR mutant N1313.35V decreases the allosteric effect, and 
lowers the Na+ dependence of δ-OR agonists, whilst retaining a low binding affinity (77 mM) in contrast 
to the wt (13.3mM)(65). Therefore, I mutated the position N1313.35 to a Valine to study the effects of a 
hydrophobic residue upon the voltage-induced movements of the Na+ ion. The position 3.35 is the only 
residue within the 15 residues of the hydrophilic pocket, which is not highly conserved, with the residue 
evenly split between hydrophilic and hydrophobic residues across all of the Rhodopsin family (68).  
The simulations of the N1313.35V mutant demonstrate a much higher sensitivity of Vm upon the Na+ ion. In 
contrast to the wt, the Na+ ion can be transiently displaced from the ABS by Vm above ~250mV in the 
mutant. Whilst voltages of >500mV are able to remove the Na+ ion from the ABS in under 0.1µs, as with 
the wt, the Vm induced movements of the Na+ ion leads to the coordination of the Na+ ion to D1283.32 within 
the TBS. Interestingly, my simulations also show that the mutation of N1313.35 destabilises the Na+ binding 
site, this is revealed as a second binding site 2 Å deeper within the ABS than the crystallographic binding 
site (z = 0Å)(Figure 3-2 C). In all simulations, the translocation of the Na+ between the ABS and TBS 
follows a highly similar pathway, in contrast to the exit to the extracellular space, where multiple pathways 
are sampled. The exit pathways seen throughout our simulations, follows that of previously published 
simulations using randomly accelerated MD (aMD) which was used force the exit of Na+ without the 
application of Vm (172).  
 
 
Figure 3-2: Effect of depolarized Vm on the position of the Na+ ion in δ-OR 
(A) Structure of the δ-OR depicting Na+ bound in the allosteric (green) and orthosteric binding sites (red). 
The binding sites correspond to coordinates of z = 0 Å and z = ~9 Å in the graphs shown in (B) and (C), 
respectively. (B and C) Z-coordinate of the internal Na+ ion in wt δ-OR (B) and in the N1313.35V mutant 
(C) under depolarized Vm, displaying translocation of the Na+ ion induced by Vm (depolarized Vm 
simulations, red trace; 0 mV control, blue trace). The approximate Vm at the time of the transitions is noted 
in the graphs. Key functionally important residues are shown as sticks and color-coded into the groups: 
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D(Glu)Arg3.50Y motif (pink), hydrophobic layer (blue), NP7.50xxY motif (green), allosteric Na+ binding 
pocket (magenta), ‘‘toggle switch’’ residue Trp2746.48 (silver), Na+ binding site in the orthosteric pocket 
(cyan). Figure adapted from (70). 
 
 
Throughout the simulations, the allosteric Na+ ion remains bound within the ABS for the duration of the 
simulation under negative or no Vm. Upon the application of hyperpolarised potentials (-250 to -500 mV), 
the Na+ ion is transiently attracted deeper into the hydrophilic pocket to the secondary binding site in the 
wt δ-OR (Figure 3-3 C), whilst the N1313.35V becomes stabilised in the second binding site (Figure 3-3, 
Figure 3-2 D). Curiously, under a large hyperpolarised potential (-1000 mV), a second Na+ ion is observed 
to enter the hydrophilic pocket, Figure 3-3 E-G shows the concurrent occupation of the two binding sites 
over substantial timespans within the wt δ-OR. 
 
 
Figure 3-3: The binding of Na+ ion at the ABS under neutral or negative transmembrane potentials 
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Z-coordinate of the allosteric Na+ ion, in the wt δ-OR (A) and N1313.35V δ-OR (C) under no transmembrane 
voltage as a control. The wt δ-OR shows stable coordination of the Na+ ion within the major allosteric Na+ 
binding site, with minor transient fluctuations into the secondary allosteric Na+ binding site. In the 
N1313.35V δ-OR mutant, the Na+ ion primarily occupies the major energy minima shown in Figure 3-4B, 
with some minor fluctuations within the pocket. Under a hyperpolarised Vm of -500mV the allosteric Na+ 
ion within the wt δ-OR (B) shows multiple transitions between the major binding site and the secondary 
allosteric Na+ binding site. In the N1313.35V δ-OR (D) mutant the Na+ ion primarily occupies the major 
energy minima shown in Figure 3-4, however is predominantly situated deeper within the hydrophilic 
pocket with minor upward fluctuations. (E-G) Shows 3 replicates of the wt δ-OR under strongly 
hyperpolarised Vm of -1000 mV, demonstrating that the inner hydrophilic pocket can bind two ions 
simultaneously. The original Na+ ion predominantly resides within the secondary allosteric Na+ binding 
site (blue trace) and is coordinated by the side chains of N3107.45, N3147.49 D952.50 and the L912.46 backbone. 
This provides enough space for the major binding site to be occupied by a second Na+ ion (red trace), 
coordinated by the sidechains of N1313.35, S1353.39 and D952.50. The dual occupation with Na+ persists for 
the majority of the simulation time. In these simulations, the second Na+ ion can either exit the hydrophilic 
pocket to the extracellular side (E) or can switch positions with the original allosteric Na+ ion (F). Figure 
adapted from (70). 
 
3.2.2 Energetics of Na+ ion movement within the hydrophilic pocket 
            
The initial simulations under supra-physiological levels of depolarisation consistently result in the 
expulsion of Na+ ions from the hydrophilic pocket to the orthosteric site on a sub micro-second timescale, 
I next investigated whether physiological or experimental Vm is sufficient to drive Na+ translocation. I 
therefore quantified the equilibrium free energy barrier for the transition of the by recording a potential of 
mean force (PMF) of Na+ along the z-axis, using umbrella sampling in the absence of Vm. 
 
 
Figure 3-4: Potential-of-mean-force profiles of Na+ translocation in the hydrophilic pocket of wt δ-
OR, N1313.35V δ-OR, and wt M2R 
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(A–C) Equilibrium potential of mean force (PMF) of Na+ translocation along the TM axis in wt δ-OR (A), 
the N1313.35V mutant (B), and the M2R (C). Arrows highlight key binding sites; the SD obtained from 
bootstrap analysis is depicted as light-blue shading. The observed energy barriers for movement of a Na+ 
ion within the hydrophilic pocket are low, and in the range of the energy provided by physiological and 
experimental membrane voltages. ABS, allosteric binding site; TBS, transient binding site. Figure adapted 
from (70). 
 
The PMF for the wt δ-OR reveals a total free energy barrier of 13 ± 2.5 kJ mol-1 for the transition between 
ABS and TBS (Figure 3-4 A). The PMF also highlights 2 energy minima, the major of which corresponds 
to that of the Na+ binding site defined by the δ-OR crystal structure (65), with the Na+ ion coordinated 
predominantly by N1313.35, S1353.39 and D952.50 (z = 0 Å). The second energy minimum at the base of the 
pocket is located towards the intracellular side (z = ~-1.6 Å), where the ion is mainly coordinated by 
N3107.45, N3147.49, D952.50 and the Leu912.46 backbone (Figure 3-4 A). The energy barrier separating these 
two minima is 5.3 ± 2.5 kJmol-1. The presence of the transient binding site shown in the previous 
simulations is reflected in local energy minima near z = 7 and 10 Å. The major energy barrier for the 
movement between the ABS and TBS arises form a constriction passage between the sidechains of N1313.35 
and W2746.48. This is reflected in the energy barrier of ~9 ± 2.5 kJmol-1 confining the Na+ ion to the 
crystallographic binding site in the extracellular direction. This barrier corresponds to a rotation of the 
sidechain of N1313.35 towards the orthosteric ligand-binding pocket, which is required for the efficient 
transfer of the Na+ ion.   
 
Curiously, the PMF of the N1313.35V mutant displays a similar free energy barrier for the passage of the 
Na+ ion from the ABS to the TBS of 13 ± 2.5 kJmol-1. In contrast to the wt δ-OR, the free energy barrier of 
the wider and smoother (Figure 3-4 B), reflecting the formation of a hydrophobic gate separating the ABS 
and TBS in the N1313.35V mutant. The PMF also shows a merging of the 2 energy minima shown in the wt 
δ-OR, with a rough outline of the 2 binding sites displayed in the PMF, and the most preferred binding site 
now located deeper within the hydrophilic pocket (z = ~-2.2 Å). The N1313.35V mutation increases the 
movement of the Na+ within the hydrophilic pocket, leading to an increased fluctuation of the Na+ ion under 
no Vm (Figure 3-3 C). 
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Figure 3-5: Non-equilibrium effect of Vm on the PMF profiles of Na+ translocation within the internal 
pocket 
(A–C) Voltage-induced tilt of the free energy surface of Na+ in the non-equilibrium case in wt δ-OR (A), 
the N1313.35V mutant (B), and the M2R (C). Increments are from 250 mV (light) to 1,000 mV (dark); dotted 
line indicates 0 mV. The underlying voltage drop was mapped by using the gating charge calculations 
displayed in Figure 3-10. The energy supplied by the voltage drop is multiplied by the gating charge e, and 
overlaid over the equilibrium PMF (Figure 3-4). The removal of kinetic traps on the pathway of the ion in 
the N1313.35V mutant becomes evident from the smoother surfaces in (B). Note that the graphs display 
relative energy differences for each voltage regime rather than absolute energy values. The black bar 
therefore denotes an energy difference of 10 kJ mol-1 within each curve, and the offset between the curves 
has been arbitrarily selected. ABS, allosteric binding site; TBS, transient binding site. Figure adapted from 
(70). 
 
The analysis of the δ-OR PMFs show that the binding of Na+ to the TBS in the orthosteric binding site is 
only 11 kJmol-1 higher in energy than the binding within the ABS in the case of the wt, and ~ 10 kJmol-1 in 
the N1313.35V mutant.  Of particular importance, the movement of the Na+ ion within the hydrophilic pocket 
(~6 Å) in both the wt and mutant δ-OR experiences energy barriers of <10 kJmol-1, whilst the complete 
removal of the Na+ ion from the hydrophilic pocket would require surmounting only a small additional 
activation barrier of ~3 kJmol-1. For comparison, the potential energy of a monovalent cation in a voltage 
gradient of ~100 mV amounts to ~10 kJmol-1 (see section 2.2.6). This demonstrates that Vm within a 
physiological range can provide sufficient energy to alter the position of the Na+ ion over substantial 
distances within the pocket, and to relocate the Na+ between the ABS and TBS.  
The N1313.35V mutation removed the steep barriers within the free energy landscape, leading to gentler 
slopes, which kinetically facilitates the movement of the Na+ ion. Similar to the effects reported for ion 
permeation through the Ca2+ release activated Ca2+  (CRAC) channel (173), the smoother energy landscape 
within the N1313.35V mutant δ-OR arises from a increased hydration of the of the hydrophilic pocket of 13 
to 18 waters molecules, this consequently raises the hydration level of the migrating Na+ ion (Figure 3-6). 
The ruggedness of the free energy landscape has important consequences for the rate of transitions, in the 
case of non-equilibrium cases, such as the application of Vm. Both the roughness of the energy surface and 
steepness of the free energy barriers contribute to the formation of kinetic traps upon the tilting of the 
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energy surface, arising from the voltage drop across the membrane (174, 175). The effect of the voltage 
drop felt by the Na+ ion along the z-axis of the hydrated pocket in a range of Vm between 250-1000 mV 
was applied to the equilibrium free energy landscape (Figure 3-5). The detailed shape of the voltage 
gradient inside the pocket was derived from the gating charge calculations of the Na+ ion movement across 
the z-axis (see section: 3.2.3). The depolarisation of the membrane results in major changes in the free 
energy surface in the pocket, with the TBS becoming the global energy minima in all studied receptors. 
The findings also show that the N1313.35V δ-OR mutation accelerates the outward migration of the Na+ ion 
by the smoothing and removal of the kinetic traps present in the wt, despite the main equilibrium energy 
barrier being similar. 
 
 
Figure 3-6: Hydration of the hydrophilic pocket 
The number of water molecules within the hydrophilic pocket shows stable hydration levels over 
microsecond time-scale simulations. A similar mean hydration level is observed between wt δ-OR (A) and 
M2R (C) of 13.0 ± 2.2 and 12.2 ± 1.8 respectively. The N1313.35V mutation leads to a slightly increased 
hydration level of 17.4 ± 2.4 water molecules in the pocket. The number of water molecules was determined 
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every 10ns from simulations at 0 mV between limits defined by the atoms Y7.53-Cα and    D3.32-Cα (±  sd). 
Figure adapted from (70). 
 
Whilst most emphasis was put upon the internally bound Na+ ion, it is important to note that throughout all 
of the simulation, I see continuous binding and dissociation events of the Na+ ions to the TBS on the 
simulation timescale, regardless of Vm. However, the passage of these Na+ ions occurs on a multitude of 
different pathways, precluding a single collective coordinate representation of the PMF, which was a 
suitable description for the transition pathway from the ABS to TBS, which displayed a single pathway 
along the Z-axis (Figure 3-7). 
Whilst no experimental data is available for gating charges in the δ-OR, I therefore next focused on the 
M2R where evidence for the effects of Vm has been previously been studied and gating charges have been 
obtained by voltage clamp recording (Table 3-1). 
 
In comparison to the δ-OR I used a subtly different protocol on the M2R due to the lower resolution of the 
crystal structure (3.0 Å), precluding the detection of Na+ within the ABS. Despite the resolution deficiencies 
of the crystal structure, the presence of Na+ has been inferred based on the conservation of the hydrophilic 
pocket and functional considerations (68). Additionally, Na+ ions have been shown previously to bind 
spontaneously from the extracellular environment in MD simulations (176, 177). Also, the hydration level 
of the M2R in comparison to the δ-OR receptor is much lower, however additional water molecules are 
able to enter the hydrophilic pocket on a timescale of nanoseconds. I therefore initially simulated the M2R 
until the pocket was fully hydrated and attracted the Na+ ion to the ABS by using a hyperpolarised potential. 
I then calculated the PMF for the observed pathway. As Figure 3-7 shows, the inward transition pathway 
is highly similar to the outward pathway of the Na+ ion in the δ-OR.  
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Figure 3-7: Comparison of inward and outward pathways of Na+ 
Pathways taken by the Na+ ion from the transient binding site to the allosteric binding site (left) or from the 
allosteric binding site to the transient binding site (right) in the wt δ-OR (color-coded according to 
simulation time proceeding from red to blue). In both directions, the Na+ ion passes centrally between 
N1313.35 and Trp2746.48, where it is coordinated by the oxygen atom from the N1313.35 sidechain and a 
cation-π interaction between the ion and the aromatic sidechain of Trp2746.48. Figure adapted from (70). 
 
The PMF of the Na+ ion transition from the ABS to the TBS in the M2R shows a clearer distinction between 
binding sites. The free energy barrier between the ABS and TBS is present slightly higher in the receptor 
at the same height as I722.53 at   ~26 ± 2.5 kJmol-1. This higher free energy barrier was attributed to a tighter 
hydrophobic gate surrounding the transition pathway of the Na+ ion by I722.53 (A982.53 in the δ-OR) 
approximately z = ~4.5 Å higher than D692.50. A minor energy well present at z = ~3 Å is due to the 
coordination with the stabilising residues: S1073.36, S4337.46 and N4327.45.  
Despite the higher free energy barrier of the M2R in comparison to the δ-OR, the energy difference between 
the ABS and TBS is comparable between the receptor subtypes (~15 kJmol-1). Therefore, a comparable 
duality between the two ion binding sites of similar free energy exists for the M2R and δ-OR in the case of 
a depolarised Vm. The higher free energy barrier in the M2R would give rise to slightly higher activation 
energy under Vm for the transition between binding sites; however, despite this, the expected rates for 
overcoming a barrier of this size would still be rapid on a physiological timescale. 
As previously mentioned, the caveats of using a lower resolution crystal structure of the M2R with respect 
to the δ-OR crystal structure, such as missing structural data (e.g. ICL3), might incur higher levels of 
inaccuracy in the M2R PMF. However, the PMF of the Na+ ion in the M2R shows a remarkable similarity 
to the free energy profile of the N1313.35V δ-OR mutant, with a mild deviation in shape at ~4.5 Å due to a 
greater constriction of the pathway. All three PMFs display similar energy minima at the binding sites 
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within the ABS between -2 and 0 Å, as well as at the TBS between 6 and 10 Å. These PMFs highlight the 
possibilities of similar free energy landscapes and binding sites being present in other Rhodopsin GPCR 
families. 
 
3.2.3 Determination of gating charges 
 
To further link the experimental and computational measurements, I characterised the movement of the Na+ 
ion under the influence of Vm, by investigating the gating charges that arise from the movement of an ion 
between the base of the hydrophilic pocket to the top of the orthosteric binding site in the N1313.35V, wt δ-
OR, and M2R.  I used a novel protocol to calculate gating charges in membrane proteins, which has been 
optimised and developed for use with CompEL double membrane simulations (151).  
Briefly, the Vm obtained for a single insulated or double bilayer system under electrochemical gradient is a 
function of the charge imbalance in the bulk solutions on either side of the membrane (Δqbulk) and charge 
imbalances within the membrane-immersed protein (Δqprot)(148). At a specific bulk charge imbalance, 
differences in Vm, averaged over time, therefore arise from a rearrangement of the charge distribution within 
the hydrophobic core of the membrane or protein embedded therein, corresponding to a measurable gating 
charge (Figure 3-8, see section 1.5.4)(148). 
 
 
Figure 3-8: Relationship between transmembrane charge imbalance and Vm over a wide voltage 
range 
The panels (A-C) shows membrane voltage plotted against charge imbalance, exhibiting a linear 
relationship. The slope of the curves denotes the capacitance, which is nearly identical in the two states of 
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the ion as can be seen. The voltage displays a right shift (black circles to red squares) due to the movement 
of the allosteric Na+ ion from the hydrophilic pocket to the orthosteric ligand binding pocket and further 
into the extracellular space. The examples display the effect seen upon movement of a sodium ion from the 
allosteric site to the transient binding site in the orthosteric pocket. (D) Minimum and maximum 
capacitances, derived from the lowest and highest Vm and vice versa measured in the M2R. (E) Vm shift 
arising from the movement of Na+ from the intracellular to extracellular solution. The movement is split 
into three major movements: Between the ABS and intracellular solution, the ABS and TBS and the TBS 
to the extracellular solution. The red line denotes the capacitance of the system with the Na+ ion in the TBS 
as shown in panel (C). The Vm fluctuations of the system were minimised by the application of position 
restraints in the x, y and z axes on the protein, and a position restraint of 200 kJ mol-1 nm-2 along the z-axis, 
on the bulk Na+ to prevent ingress of an additional ion into the orthosteric ligand-binding pocket. In this 
way, the gating charge arising only from the movement of the allosteric Na+ ion was recorded. The standard 
deviation of the variation of Vm falls between 8-30 mV using the above protocol for each data point on the 
graphs, as shown here by the horizontal error bars. Figure adapted from (70). 
 
Figure 3-10 shows that the movement of the Na+ ion from the ABS to the extracellular domain gives rise 
to a maximum gating charge of 0.42 ± 0.03 e, 0.63 ± 0.03 e and 0.53 ±0.02 e for the wt δ-OR, N1313.35V 
δ-OR and wt M2R respectively. It is worth noting, that in the wt δ-OR the residue N1313.35 was unrestrained 
to prevent clashes with the Na+ ion throughout the gating charge scan, upon the restraint of the side chain, 
a gating charge of ~0.6 was also calculated. For the transfer of the Na+ between the ABS and TBS, my 
calculations predict gating charges of up to 0.3e, for all studied receptors. As shown in Table 3-1, the 
experimental gating charges of the M2R span between 0.5 to 0.85 e (118, 126), however, the majority of 
the experimental  measurements on the wt and mutant M2R converge near ~0.5 e. For the α2A adrenergic 
receptor, a gating charge of 0.5 e has also been reported (113). The gating charges measured in my 
simulations are therefore in excellent agreement with the gating charges measured in previously in the M2R 
and other GPCRs (112, 113, 126, 168).  
 
The results demonstrate that the movement of a charge inside the GPCR must cover a substantial distance 
along the membrane normal to result in a gating charge near 0.5 e. More spatially restricted rearrangements 
of charged or polar groups are unlikely to explain such a large value for the gating charge. However, if 
many charged residues move simultaneously a larger gating charge could be recorded. Of note, even under 
a Vm of 1000 mV I did not observe extensive movement of any other charged or polar residues within the 
hydrophobic layer of the membrane.  
 
To substantiate this notion, I then tested the maximum gating charge that would arise from the 
conformational change of inactive to active form, as this can be assumed to reflect the upper boundary of 
the conformational variability of the receptor (Figure 3-9). The M2R receptor has been crystallised in both 
the inactive and active conformations (131, 153). Despite the poor resolution of the structures and the use 
of a nanobody to stabilise the active state, the conformational change will encompass the pertinent 
movements. I used the same protocol as previously described, the transition from the inactive to active 
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conformations of the M2R leads to a gating charge of 0.13 ± 0.02 e (if the Na+ movement is disregarded). 
This approach includes the entire protein in the transition, and therefore the conformational changes of the 
charged residues at the DR3.50Y motif, E6.30 and D3.32 are considered. The calculated gating charge for the 
inactive to active conformational change is thus too small to serve as an explanation for the experimentally 
observed values, unless the movement of the cation is included. 
 
 
 
 
Figure 3-9: Maximal movement of charged protein residues upon the transition of M2R from the 
inactive to the activated conformation 
(A) Conformational change of the M2R from the inactive state (left, brown) to the active state (right, silver), 
representing an upper limit to the known receptor conformational dynamics and the movement of charged 
residues. Charged residues are shown as spheres for clarity (positive, blue; negative, yellow). A small gating 
charge of only ~0.13e is linked to the activation transition of the receptor. (B) Comparison of the overall 
conformation of inactive (brown) and active M2R (silver; PDB: 3UON and 4MQT, respectively), TM 6 is 
shown separately for clarity.  
 
Other charges, e.g. potassium and protons, however, can easily be imagined to undergo the same 
movements described for the crystallographic Na+ ion, and would lead to an experimentally 
indistinguishable gating charge. I therefore tested the hypothesis that the movement of a proton along the 
same pathway through the hydrophilic pocket would give rise to the same gating charges. The ABS is 
formed by the ultra conserved D2.50 located approximately within the center of transmembrane domain. The 
protonation state has been addressed in multiple studies, where its pKa has been calculated to be ~7 (80, 
178–180). The pKa of ionisable groups within the hydrophobic layer of the membrane would be highly 
sensitive to changes in the Vm (181), thereby allowing changes in the Vm to modulate the protonation state 
of said residues. Unless a cation such as the Na+ ion binds to D2.50, it is easy to envisage this residue to 
become protonated, and due to its location within the membrane, to be highly sensitive to Vm. The 
orthosteric ligand-binding site contains a second ionisable side chain within the TBS (D3.32). I calculated 
the gating charges arising from the transfer of a proton from D2.50 via D3.32 to the extracellular solution 
(D173ECL2) in the M2R. The three aspartates were protonated and deprotonated in sequential order from 
D2.50 to D3.32 then D173ECL2. As can be clearly seen, a voltage induced proton transfer from D2.50 via D3.32 
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to the extracellular space results in the recording of a gating charge, which is identical to that of a 
monovalent cation (Na+) along the same distance. As shown in Figure 3-10, the gating charges are 
comparable with experimental values, as the movement of 1 Na+ from the intracellular solution to the 
extracellular solution in the wt M2R gives rise to a gating charge of 1 e.     
 
 
Figure 3-10: Gating charge resulting from the movement of a Na+ ion or a proton 
(A) Gating charge arising from the movement of Na+ within the internal pocket of the M2R (black), wt δ-
OR (blue), and the N1313.35V δ-OR (red), calculated with a step size of 2.5 Å. The maximal gating charges 
for the movement from the ABS to extracellular solution are 0.42e, 0.53e, and 0.63e for the wt δ-OR, wt 
M2R, and N1313.35V δ-OR, respectively. The green circles show the gating charge that would arise from a 
similar transfer of a proton from D2.50 to the extracellular surface of the M2R via D3.32 and D173 (~0.5e). 
(B) Na+ positions corresponding to the allosteric binding site and the top of the orthosteric binding pocket 
(the Na+ is colored red and blue respectively). (C) Pathway taken by the Na+ ion from the hydrophilic 
pocket to the extra- cellular bulk solution in the δ-OR (color-coded according to simulation time proceeding 
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from red to blue); TM helix 5 has been omitted for clarity. The errors were estimated from the variation 
within the slopes of the charge- voltage relationships (see Figure 10D). Figure adapted from (70). 
 
 
 
3.3 Discussion 
 
The physiological importance of Vm in all cells is uncontested (122, 182), whilst the effect of Vm upon 
structure and function of the majority of integral membrane remains largely ignored. However in recent 
years, there has been increasing evidence supporting a direct influence of Vm upon the Rhodopsin family 
of GPCRs. For example, Vm has been demonstrated to modulate the agonist mediated activation of the α2A 
adrenergic receptors (113), agonist binding and downstream signalling of the muscarinic receptors (112, 
117, 183) and downstream signalling of the P2Y1 receptor purinergic receptor (116). The movement of 
gating charges has also been demonstrated in 2 distinct GPCR sub-families (α2A adrenergic and muscarinic 
receptors) (112, 113, 118, 126). These receptors are expressed predominantly within excitable tissue, 
therefore it is conceivable that Vm could act as an important physiological control mechanism (114, 115). 
However, the precise mechanisms underpinning voltage sensitivity in the Rhodopsin family of GPCRs and 
the effects of Vm on the receptor conformation has so far remained elusive.  
 
Our μs-timescale atomistic simulations of the δ-OR and M2R demonstrates that the allosteric Na+ ion is the 
most highly mobile charge in the receptors TM domain. The protein does not undergo any significant 
conformational changes of other charged groups within the transmembrane domain, including D3.32, D2.50 
and the DR3.50Y motif. The majority of the 16 hydrophilic pocket-lining residues are highly conserved in 
the Rhodopsin GPCR family, with the interesting exception of position 3.35, which can be occupied by 
polar groups e.g. asparagine in the δ-OR, or hydrophobic residues e.g. Valine in the M2R (Figure 1-13). 
My results therefore may be applicable to most of the Rhodopsin GPCR family, which contain the same 
internal structure.   
   
3.3.1 Gating charges arising from the allosteric Na+ ion 
 
My computational studies show that a depolarised Vm of near physiological amplitude is capable to move 
the Na+ ion from the ABS through the orthosteric site to the extracellular space, whilst demonstrating that 
this translocation can generate gating charges of between 0.42 and 0.63 e in the δ-OR and M2R. For the 
m1 and m2 muscarinic receptors, gating charges in the range of 0.55 – 0.85 e and 0.5 e for the α2A adrenergic 
receptor were reported upon depolarisation (Table 3-1).  The exceptional agreement between the 
experimental gating charges and the those caused by the movement of a cation (Na+ or proton), which I 
observed, provides a plausible structural and mechanistic explanation for the experimentally measured 
gating charges. Of note, the only mutation that has successfully abolished gating charges is the mutation of 
D2.50 to an alanine in the M2R (126). Although, expression of this mutation is particularly troublesome, as 
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noted by the authors, that the lack of gating charge could be attributed to low expression of the receptor or 
the D2.50 could play a key role in the mechanism of voltage sensing. The lack of gating charge movements 
in the D2.50A mutant are in agreement with our results that the transfer of a cation from the ABS to the 
extracellular due to D2.50 is the Na+ ions counter ion, and forms a strong support for the latter explanation, 
i.e. the crucial role of the allosteric Na+ binding pocket for the voltage regulation of GPCRs. In further 
agreement with our simulation, there is a parity of charged residues within the hydrophobic layer, which 
could provide an alternate explanation (Figure 3-11).  
 
 
Figure 3-11: Charged amino acid distribution between the M2R and wt δ-OR 
The figure shows the disparity of charged residues within the δ-OR (left) and M2R (Right). In both 
receptors, only the charged residues D2.50 and D3.32 are within the transmembrane domain. Charged residues 
are shown as spheres for clarity (positive, blue; negative, yellow) and the Na+ ion is shown as a purple 
sphere. 
 
Moreover, the movement of the gating charge has been shown to affect ligand binding in the orthosteric 
ligand binding site (118, 126, 184), which is in agreement with our computational studies that a cation can 
move between the ABS, TBS and the extracellular space. Recent experiments have revealed that Vm 
modulates both G-protein dependent and G-protein independent signalling pathways in the muscarinic 
receptors, but the magnitude and direction of the allosteric modulation is highly dependent on the binding 
mode and precise chemical structure of the agonist (112). The voltage sensitive cation in my simulations 
can either relocate to or cross the orthosteric ligand-binding site, in a ligand dependent fashion (126).  
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The majority of the experimental measurements of GPCRs have been made in the presence of extracellular 
Na+ (112, 113, 126), whilst other experiments were undertaken with no extracellular Na+, however other 
cations were present, such as K+, Ca2+ and the organic cation N-methyl-D-glucamine (NMDG) (118). It 
has been long known that other monovalent and divalent cations can interact with the hydrophilic pocket 
to a varying extent in previous experimental and computational studies (100, 106). Additionally, it has been 
shown that the commonly used organic cation amiloride is able to bind directly to the ABS and induce a 
similar allosteric effect as Na+ (185, 186).  Under physiological conditions, the most likely source of the 
gating charge is Na+ due to its high extracellular concentration, and its clear detection in close proximity to 
the residue D2.50 in the A2A adenosine and δ-OR crystal structures (64, 65).  
 
3.3.2 Gating charges arising from protons 
 
It has previously been shown that the D2.50 is likely to titrate near the pH 7 when the ion is not bound (180). 
I have therefore tested the likely possibility that a voltage induced deprotonation of the D2.50 due to a pKa 
shift and subsequent transfer of a proton to the extracellular space, could give rise to a similar gating charge. 
As expected, the migration of the proton gives an identical gating charge over the same distance to that of 
the monovalent cation Na+. As previously mentioned, other cations and organic cations can bind to D2.50, 
and theoretically undergo the same transition if their concentration is high enough or upon removal of Na+ 
(185). I cannot exclude a more dynamic interplay between Vm, cations and the protonation state of the D2.50, 
as throughout the simulations the protonation state of all titratable residues were fixed. The dynamic 
protonation of D2.50 dependent on the position of Na+, or upon the removal of the Na+ the protonation of 
the D2.50 could be modulated by the Vm, could play a role as a highly sensitive and robust voltage sensor or 
a subset of the sensor. Whilst some preliminary studies have been undertaken on the protonation state of 
key residues in the Rhodopsin GPCR family, very little is known on the interplay between Na+ ion position 
and D2.50 protonation state (96, 178, 180, 187).  
 
The allosteric Na+ binding site residing deep inside the hydrophilic pocket is conserved across the majority 
of Rhodopsin family GPCRs, with the exception of the visual rhodopsins, my results predict that the voltage 
sensitivity and gating charge movements could be a general feature of this class of membrane proteins. The 
receptors I studied in this chapter are all predominantly expressed in excitable cells, so it is tempting to 
speculate about the regulation of GPCRs by Vm and its physiological role.  
 
It is interesting to consider the similarities and differences to the more canonical voltage-sensing domain 
(VSD), for example those commonly found in voltage gated K+ and Na+ channels (169). These channels 
contain a highly focused electric field through the VSD, which exist as an array, and acting together to 
allow for a greater displacement of a greater gating charge in total, ensuring excellent sensitivity to millivolt 
changes in the Vm. In contrast, the voltage sensing mechanism proposed here seems to be more highly 
adapted to large scale Vm changes in the order of ~200 mV (118, 126). Notably, the main voltage sensing 
mechanism I suggest for GPCRs lies outside the polypeptide chain and involves the movement of a 
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monovalent cation (Na+) through the conserved hydrophilic pocket, or the modulation of the pKa of the 
ultra conserved residue D2.50, as opposed to the movement of a charged segment of the protein itself (Figure 
3-12). 
 
Figure 3-12: Graphical Representation of the Suggested Voltage- Sensing Mechanism in GPCRs 
The hydrophilic pocket, accessible from the extracellular face only, connects the orthosteric ligand and the 
Na+ binding sites in GPCRs. A Na+ ion is bound to a conserved site near the ionisable residue D2.50. The 
position of the ion within the pocket strongly responds to changes in membrane voltage. The movement of 
a cation along the TM axis in the water-filled pocket leads to a gating charge of ~0.5e when the ion travels 
from its allosteric binding site to the top of the ligand binding pocket. In Na+-free conditions, a nearly 
identical gating charge can be elicited by a voltage-induced change in the protonation state of D2.50 and 
movement of a proton. The side chain of D2.50 is likely to be in a protonated state if no Na+ ion is bound. In 
both cases, the voltage induced repositioning of cations involves a change in the ionic interactions within 
the allosteric binding site and the orthosteric ligand-binding site. Figure adapted from (125).      
 
Previous experimental work has shown that mutation of the residues surrounding D2.50 in the δ-OR receptor 
severely disrupts the signal bias between G-proteins and β-arrestin at a basal signalling level, as well as 
disrupting Na+ binding to the receptor. The results presented in this chapter, show that Vm affects the 
occupation of the ABS with Na+. Thereby indicating that Vm, and therefore the excitation state of the cells 
could have an impact on the signal bias between pathways in these studied receptors. The results presented 
here provide a rational for a new range of electrophysiology and receptor-functional experiments to tease 
apart the interplay between signal bias, Vm, Na+ effect, pH and ligand specific allostery on GPCRs.  
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Chapter 4. Intracellular Permeation of Na+ in an active 
state GPCR 
 
4.1 Introduction 
 
Since the first crystal structure of rhodopsin almost two decades ago (188), a number of structures have 
been solved, revealing conformational changes between the inactive and active state receptors, including 
common movements in the transmembrane helices and conserved residues termed “microswitches” (63, 
189). However, despite a wealth of structural information, it is not understood how ligand binding leads to 
downstream activation of the intracellular effector proteins. There are major issues arising from crystal 
structures and wet lab experiments including: first, the x-ray structures represent static snapshots of highly 
dynamic receptors, crystallised under non-physiological conditions, which is likely to distort or mask 
crucial information, such as the internal hydration of the receptor. Second, wet lab experimentalists 
predominantly concentrate on specific signal pathways, either G-protein or β-arrestin, thereby potentially 
missing alterations in signal pattern. 
 
4.1.1 The Na+ effect 
 
Interestingly, the active receptor conformations display a collapsed ion binding pocket around the D2.50, 
which is unlikely to be able to bind cations (64, 74, 190). It was therefore proposed that the bound cation 
leaves the hydrophilic pocket during receptor activation by a ligand or upon formation of a receptor-G-
protein complex. However, how this cation is displaced and which pathway it follows is currently unknown, 
though the forces felt by the ion such as the Na+ ion concentration gradient as well as the presence of a 
hyperpolarised membrane potential, will drive the ion towards the cytoplasm. 
 
Throughout this chapter, I therefore investigated the link between receptor activation, the fate of the bound 
Na+ ion and its implications for signal transduction across the membrane. I used equilibrium and non-
equilibrium atomistic simulations of the well-characterised m2 muscarinic receptor (M2R). The M2R is an 
excellent model for this study, due the availability of both inactive and active state crystal structures 
including a large array of experimental data (see Chapter 1 and 3). When addressing questions on ion 
binding, it is important to take into account the various physiologically relevant electrochemical conditions.  
 
4.1.2 Interplay between GPCRs and the electrochemical gradient 
 
As I showed in Chapter 3, depolarised potentials can expel the Na+ ion via the orthosteric ligand binding 
site. However, in contrast to the excitable cells in which depolarised potentials exist, the majority of cell 
types exist in a hyperpolarised state. Therefore, the Vm and Na+ concentration gradients are acting in 
synergistic manner, pushing the allosteric Na+ ion through the receptor (Figure 4-1).    
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Figure 4-1: Ionic and voltage gradients across a cell membrane 
The constituents in a simplified electrochemical gradient: electrical and Na+ concentration gradient. (Left) 
Displays the electrical gradient from positively charged extracellular surface to the negatively charged 
intracellular surface of the membrane. The approximate strength of the electric field is 108 Vm-1. (Right) 
Displays the concentration gradient of Na+ from ~140mM in the extracellular to the low 5mM intracellular 
concentration. In this particular case both the Na+ concentration gradient and the Vm act synergistically. 
However, they can oppose each other, as is the case of K+ concentration gradient and Vm.        
 
4.1.3 Chapter overview 
 
Throughout the previous chapter, I observed that the movement of a cation from the hydrophilic pocket 
was possible under physiological conditions in the inactive receptor. However, here I focus on receptors 
present under a hyperpolarised potential and an ionic gradient. I observed that the Na+ ion can readily 
transverse the hydrophobic layer of the active receptor migrating to the cytoplasm. This result implies that 
an exchange of Na+ or other monovalent cations from the extracellular space to the cytoplasm is an 
important step in receptor activation. Furthermore, the movement of Na+ within the receptor is tightly 
coupled to the protonation state of the D2.50.  
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4.2 Results 
 
4.2.1 GPCR activation opens a hydrated pathway through the receptor 
 
As mentioned earlier the binding site for the Na+ ion in the active crystal structures appears to adopt a 
collapsed conformation unable to accommodate the Na+ ion. Therefore I was first interested whether the 
conformational change from the inactive to active receptor state renders the pocket sterically incapable of 
coordinating the Na+ ion. I started from the inactive state structure of the M2R (PDB: 3UON) and using a 
targeted MD approach gently drove this conformation to the active state of the receptor (PDB: 
4MQT)(Figure 4-2 A). My simulations indicate that the hydrophilic pocket within the active state of the 
M2R retains sufficient space for the ion. The ion is unlikely to move under these conditions, due to the 
electrostatic attraction between the ion and the negatively charged side chain of the D692.50. Ion binding is 
maintained  throughout and after the transition from the inactive to active conformation induced by targeted 
MD (Figure 4-2 B).  
 
 
 
Figure 4-2: Observations during a targeted MD simulation from the inactive to the active state of 
M2R 
(A) The red and blue lines correspond to the RMSD of TM6 relative to its inactive and active conformations 
(PDB: 3UON, 4MQT), respectively. The orange and grey lines correspond to the RMSD of all 
transmembrane helices relative to their inactive and active conformations, respectively. The RMSD of TM6 
with respect to the active state structure remains below 1 Å following the transition (blue line: TM6 vs. 
active). The RMSDs of all seven TM helix residues were calculated using the backbone of residue numbers 
25-46, 60-83, 96-123, 140-158, 189-210, 388-408, 422-443; those of TM6 from residues 388-408. (Β) A 
stable position of the Na+ ion is seen throughout the transition of the M2R from the inactive to active 
conformation. The Z coordinate is reported relative to the D1033.32 Cα atom in the orthosteric ligand-
binding pocket. Figure adapted from (156).       
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As expected, throughout the initial targeted MD simulation, I observed a widening of the intracellular 
portion of the transmembrane helices (TM 6 and TM 2) below the hydrophilic pocket during the 
conformational change. The widening allows the formation of a hydrated pathway connecting the 
orthosteric ligand binding site, the hydrophilic pocket and the G-protein binding site (Figure 4-2 B). Within 
the inactive structure a slim hydrophobic layer exists, delimiting the hydrophilic pocket and the G-protein 
binding site. Upon activation, the NP7.50xxY motif within this layer undergoes substantial conformational 
changes as evidenced by the Y4407.53 sidechain. The formation of the hydrophilic channel, allows the 
sidechain of residue Y4407.53 to occupy multiple conformation, consequentially modulating the shape of 
channel. The simulations show two major conformations of the sidechain of Y4407.53 following the 
transition, a upward state, also observed in the inactive crystal structure (PDB: 3UON, Figure 4-3 D) and a 
downward state similar to that observed within the active crystal structure (PDB: 4MQT, Figure 4-3 E and 
Figure 4-4). The presence of a hydrated channel connecting the receptor ligand and effector binding sites 
has previously been reported in simulation studies of the A2AR and 5-HT1A receptors, however the Na+ ion 
was not taken into account in these simulations (69, 191). 
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Figure 4-3: Major structural features and internal hydration of class A GPCRs in the inactive and 
active state as shown by the M2R  
(A) The main structural features of class A GPCRs, as exemplified by the M2R, include seven TM helices 
(blue), an extracellular ligand binding site, the intracellular effector (G-protein) binding site as well as 
conserved and functionally important residues termed microswitches (selected ones are highlighted). The 
vertical axis (Z-coordinate) and all positions stated in the text use the Cα atom of D1033.32 as reference. (B) 
Conformation of inactive M2R (PDB: 3UON) during the simulations showing the presence of the 
hydrophobic layer separating the hydrophilic pocket and effector binding site. (C) After transition to the 
active state (PDB: 4MQT), and further simulation, M2R displays a continuous water channel connecting 
the orthosteric ligand binding site, hydrophilic pocket and effector binding site. (D-E) Representative 
frames corresponding to the most populated sidechain states showing residue Y4407.53 in an upward (D) 
and downward conformation (E). Water molecules are shown in red (surface representation); the position 
of the allosteric Na+ ion, as obtained from our initial simulations, is shown as a green sphere, and residues 
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forming the hydrophobic layer (yellow) as well as the bound ligand (carbachol, light green) are depicted in 
stick representation. Figure adapted from (156). 
 
4.2.2 The position of the internal Na+ ion is coupled to protonation of D692.50 
 
I was next interested in the interplay between the Na+ ion and the highly conserved titratable residue D692.50. 
Numerous computational studies have examined the protonation states of the residues D692.50, D1033.32, 
the D(E)R3.50Y motif and Na+ binding, and their functional implications on activation of several members 
of the Rhodopsin family of GPCRs (176, 180, 187).  Here, I focused upon the interactions between the 
location of the Na+ ion within the receptor and the protonation of D692.50. In collaboration with Catarina A. 
Carvalheda and Dr Andrei Pisliakov, we carried out pKa calculations of the residue D692.50. Conformational 
snapshots were taken every 2 ns between 10 and 20 ns from my PMF window simulations (total > 800 
snapshots). To separate the effects of the conformation of Y4407.53 sidechain on the pKa of D692.50, the pKa 
calculations were run with the Y4407.53 in an upward and downward conformation (Figure 4-3 D, E). The 
effects of the Na+ ion position upon the pKa of D692.50 were evaluated in 2 dimensions; the z-axis as 
described in the PMFs (Figure 4-11) as well as the distance of the ion to the titratable group.  
 
 
 
Figure 4-4: Distribution of distances between the Y4407.53 (OH) and the D692.50 (Cα) atoms 
Shown here is a representative distance distribution between the atoms Y4407.53 (OH) and D692.50 (Cα) 
under a Vm of ~250 mV, with a protonated D692.50. The distributions display the two distinct conformational 
states of the residue Y4407.53: an upward conformation clustered at  ~8 Å and a downward conformation 
clustered around ~12.5 Å. Figure adapted from (156). 
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Figure 4-5 shows a clear shift in pKa values resulting from the location of the Na+ ion; therefore it is highly 
likely that the protonation state of D692.50 is modulated by the location of the cation. The pKa calculations 
show that if the cation is within 3-5Å of D692.50 it leads to a pKa of between ~3-4, thereby stabilising the 
negatively charged form of the aspartate. The pKa of the Na+ bound D692.50 displays a similar value to that 
of a solvent exposed aspartate (pKa 4). In contrast, upon displacement of the cation to distances of >5Å, the 
pKa increases substantially to values of ~10 and ~12 for the upward and downward conformations 
respectively. A substantial pKa shift may be due to the location of D692.50 within the core of the membrane, 
surrounded by many non-polar residues and water molecules with low mobility. Interestingly, the sidechain 
conformation of Y4407.53 does not have a substantial effect upon the final pKa values, only accentuating the 
pKa shift between 4 and 6 Å of Na+-D692.50 distance. Transient fluctuations of the Na+ from its binding site, 
which are facilitated by activation induced conformational changes within the hydrophilic pocket as well 
as Vm induced movements, can therefore be sufficient to lead to the protonation of D692.50. 
 
 
Figure 4-5: Proximity of the Na+ ion modulates protonation of D692.50  
Continuum electrostatics calculations of the pKa of the D692.50 sidechain using a multitude of M2R 
conformations obtained from our atomistic simulations in the carbachol-bound active state, both for 
Y4407.53 in the upward (left) and downward (right) conformations. The pKa is shown as a function of Z, the 
separation between the Na+ ion and the Cα atom of D1033.32, which marks the orthosteric ligand binding 
pocket, along the TM axis (see Figure 4-3 A). The data points are, in addition, coloured according to their 
distance to the D692.50 sidechain. The black continuous line, a smoothed spline fit, indicates the approximate 
average pKa for each separation for illustrative purposes, and the dashed black line shows a pKa of 7. Figure 
adapted from (156). 
 
For the protonation of D692.50 to occur, a proton has to reach the core of the receptor from the bulk solution. 
Here, I propose that the most likely proton entry route is from the extracellular solution, following the 
negative Vm gradient. In the case of the M2R and other Rhodopsin GPCRs, of which ~20% have a conserved 
D3.32 within the orthosteric binding pocket, a proton could be transferred between the two sites via a short 
chain of water molecules (80). In the apo state (no ligand), the pKa calculations of the M2R indicate that 
the D3.32 is generally protonated (pKa = 11.2±1.7), whilst upon ligand binding the pKa is strongly 
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downshifted (pKa = 7.6±1.9). The protonation shift of D3.32 could therefore facilitate shuttling of protons to 
D2.50; this could additionally be initiated by the coordination of a second cation within the orthosteric site 
(seen in the majority of simulations). Furthermore, as the sequence of activation is still in contention, if a 
G-protein-receptor complex is formed before agonist binding, the residue D2.50 is easily accessible from the 
extracellular space via the deep water filled hydrophilic pocket. It has been previously hypothesized, that 
agonists and not antagonists, provide a hydrated pathway circumventing the ligand and thereby connecting 
Na+ binding site and the extracellular space upon activation (191).  
 
The protonation state of D692.50 demonstrates a large effect on the stability of the active structures 
throughout the simulations. Under both equilibrium and non-equilibrium conditions, the active state 
remains stable when the D692.50 is modelled as neutral (Figure 4-6, Figure 4-7), whilst when the D692.50 is 
charged the active receptors is more likely to revert back to the inactive state. This observation provides 
additional support for the importance of the Na+ ion’s location within the Na+ binding pocket, which as 
shown in Figure 5 is linked to the protonation state of D692.50. The expulsion of the Na+ ion and thereby 
the protonation of D692.50  is an important step in receptor activation.  
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Figure 4-6: Backbone RMSD values during equilibrium MD simulations of the active state M2R 
The red and blue lines show RMSD values with respect to the inactive and active conformations of TM6 
(PDB: 3UON, 4MQT), respectively, while the grey and orange lines show the RMSD of all TM helices 
relative to their inactive and active conformations. D692.50 was either charged (A, B) or neutral (C-J). When 
the Na+ ion is still bound to D692.50 in simulations with a charged D692.50, the receptor can switch back to 
the inactive conformation in some trajectories (see panel B; compare grey and orange lines). In contrast, 
all simulations with a neutral D692.50 remain stable in the active conformation. Figure adapted from (156). 
 
4.2.3 Simulations under negative Vm show ion movement to the cytoplasm 
 
In order to follow the trajectory of the Na+ ion under more physiological conditions, I conducted atomistic 
simulations using the computational electrophysiology (CompEL) protocol (147) on the active 
conformation of the M2R. To apply conditions that represent the physio-chemical features of the cell-
membrane, I used a physiological Na+ ion gradient of 150:10mM across the membrane, from the 
extracellular to intracellular side. Additionally, I employed a small charge imbalance across the membrane 
evoking a hyperpolarised Vm of 250 and 500mV. Whilst the applied Vm is mildly supra-physiological, these 
voltages were chosen due to speed up any Vm related effects as well as optimizing the CompEL system 
efficiency. As discussed in the previous section, the wide range of pKa values displayed by D692.50 
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precluded a single protonation state, therefore its sidechain was modeled in both the charged and neutral 
forms. Figures 4-6, 4-7 and 4-8 show the stability of the active conformation of the M2R under the four 
conditions simulated (four replicates in each condition). Interestingly in three out of eight simulations, in 
which D692.50 is charged and a Na+ ion is still bound within the receptor, slide back into a inactive 
conformation. In contrast, simulations with a neutral D692.50 are never observed to drop back into the 
inactive state but occasionally adopt an intermediary conformation.  
 
 
 
Figure 4-7: Backbone RMSD values during MD simulations of the active state M2R under Vm 
The red and blue lines show RMSD values with respect to the inactive and active conformations of TM6 
(PDB: 3UON, 4MQT), respectively, while the grey and orange lines show the RMSD of all TM helices 
relative to their inactive and active conformations. The active state simulations were carried out under a Vm 
of -250mV (A-D, I-L) or -500mV (E-H, M-P) and the protonation states of D692.50 were either charged (A-
H) or neutral (I-P), as shown in the main text (Figs. 3, S8). When the Na+ ion is still bound to D692.50 in 
simulations with a charged D692.50, the receptor can switch back to an inactive conformation (A, D and F; 
compare grey and orange lines). In contrast, simulations with a neutral D692.50 can show a change to an 
75 
intermediary conformation, but no drop back to an inactive-like state (grey and orange lines). Figure 
adapted from (156).   
 
 
Figure 4-8: Hydration of the hydrophilic pocket and intracellular effector-binding site 
The number of water molecules within the hydrophilic pocket shows a level hydration throughout the 
simulations, with a slight decrease in hydration with a neutral D2.50 (Table 4-1). The number of water 
molecules within the intracellular effector-binding site is stable in the majority of simulations, with the 
decrease of water molecules correlated with the collapse of some systems to the inactive state (Fig S4, 
Table S1). The hydrophilic pocket was defined as z = ±4Å from the D692.50 Cα atom (blue lines) and the 
hydrated channel between the z = -4Å from the D2.50 Cα atom and the z-coordinate of the R3.50 Cα (red 
lines). The number of water molecules were recorded every 2ns throughout the simulations. Simulation 
conditions were as follows: (A-D) Vm: -250mV, D2.50: charged (E-H) Vm: -500mV, D2.50: charged (I-L) 
Vm: -250mV, D2.50: neutral (M-P) Vm: -500mV, D2.50: neutral. Figure adapted from (156). 
 
In the simulations undertaken at -250 mV in the active state, the bound Na+ ion displays a significant degree 
of mobility, regardless of the protonation state of D692.50 (Figure 4-10 A, B). The Na+ ion is predominantly 
coordinated within the Na+ binding pocket by the residues D692.50, S1103.39, N4357.45 and S4337.46. Even 
whilst under a small Vm, a distribution of distances between the Na+ ion and the Cγ of the residue D692.50 
is seen, in which distances of >4.5 Å are not uncommon (Figure 4-9). As displayed by the pKa calculations, 
only small excursions of the ion from its binding site on this scale are sufficient to have a significant impact 
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upon the pKa and therefore the protonation state of the D692.50 side chain (Figure 4-5). I consequently 
investigated the effects of a protonation state change of the D692.50 residue in the active conformation.  
 
 
Figure 4-9: Distances between the Na+ ion and D692.50 
Distance distribution between Na+ and D692.50 (Cγ) in the active state of M2R under -250 mV and charged 
D692.50. Figure adapted from (156). 
 
The simulations reveal that, following the protonation of the key residue D692.50, the Na+ ion can readily 
pass through the hydrated channel present within the active conformation of the M2R. Upon the 
neutralisation of D692.50, the Na+ ion is expelled to the cytoplasm in three out of four simulations under a 
mild hyperpolarised Vm (-250 mV) (Figure 4-10 A, C). At -500 mV, the effect is expectably more 
pronounced and expulsion of the ion to the cytoplasm is seen within all simulations (Figure 4-10 B, C). In 
contrast, in simulations with a negatively charged D692.50, the transition to the cytoplasm was observed in 
only one out of eight simulations at the raised Vm of -500 mV (Figure 4-10 B). Interestingly, the trajectory 
of the Na+ ion to the cytoplasm follows a highly similar route in each case, which is irrespective of the side 
chain conformation of Y4407.53 (Figure 4-10 C). 
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Figure 4-10: Migration of the Na+ ion across the receptor to the intracellular side 
Z-coordinate of the Na+ ion in the M2R under a hyperpolarised Vm of -250 mV (A) and -500 mV (B). 
Black/grey lines denote simulations with a charged D692.50; purple, green and red lines display simulations 
with neutral D692.50. Trajectories of the Na+ ion moving from the hydrophilic pocket, accessible from the 
extracellular space, into the intracellular bulk solution at (C) -250 mV and (D) -500 mV (example 
trajectories are shown for each condition, please see Table 4-1 for a complete list). The color used to display 
the Na+ ion corresponds to the trajectories shown in panels A and Β, respectively. The Y4407.53 upward and 
downward conformations are shown in green. The pathways of the ion towards the intracellular side are 
almost indistinguishable from each other until the ion passes Y4407.53. Thereafter, the pathways diverge to 
some degree due to the widened exit region to the cytoplasm. Figure adapted from (156). 
4.2.4 Energetics of Na+ ion movement to the cytoplasm 
 
To accelerate the Vm related movements, the initial simulations were undertaken at slightly supra-
physiological levels of Vm. Therefore, to ascertain the physiological relevance of the previously observed 
ion transitions, I next evaluated the detailed equilibrium energetics of the Na+ ion movements along the 
exit pathway (Figure 4-10 C) without any applied gradients. I calculated a Potential-of-mean-force (PMF) 
for the translocation of the cation in the four conditions described previously in the section 4.2.1. In addition 
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to quantifying the influence of the D692.50 protonation state, I also examined the role of the conformation 
of the residue Y4407.53, which significantly modulates the width, shape and hydration level of the channel 
into the cytoplasm (Figure 4-11). 
 
 
Figure 4-11: Energetics of Na+ translocation from the hydrophilic pocket to the intracellular side 
Equilibrium potential of mean force (PMF) profiles of the energetics of Na+ translocation along the Z-axis 
in M2R without any applied voltage or concentration gradients. Four relevant states were considered: (Left) 
negatively charged D692.50 (black) or neutral D692.50 (red) with the Y4407.53 sidechain in an upward 
conformation; (Right) negatively charged D692.50 (black) or neutral D692.50 (red) with a downward-oriented 
Y4407.53 sidechain. The standard deviation of the PMF, obtained from Bayesian bootstrap analysis, is 
depicted as shaded area. For each PMF, the intracellular bulk solution was used as a reference, and the 
range of positions adopted by the Y4407.53 sidechain is denoted by blue dotted lines. 
 
Regardless of Y4407.53 conformation when the D692.50 is negatively charged, the free energy difference 
between the Na+ binding pocket and the cytoplasmic bulk solution is in the order of ~30 kJ mol-1. 
Accordingly, as long as the key Na+ binding residue D692.50 remains negatively charged, the active 
conformation of the M2R retains the Na+ ion with relatively high affinity. As expected, the major energy 
barrier to the migration of the Na+ ion into the cytoplasm is situated near the sidechain of the residue 
Y4407.53. When it is in the upward conformation, the free energy barrier amounts to ~41 kJ mol-1, whilst in 
the downward conformation, the barrier increases by ~8 kJ mol-1 to 48 kJ mol-1 (Figure 4-11).    
 
The pKa calculations of D692.50 show a clear dependence on the position of the Na+ ion. Even a moderate 
displacement of the Na+ ion from the key binding residue D692.50 is likely to lead to a protonation state 
change of the aspartate. In accordance to this, I also calculated the PMFs along a similar trajectory through 
the hydrated pathway with a neutral D692.50 (Figure 4-11; red lines). In contrast to the charged D692.50, the 
neutral state shows no affinity to the Na+ ion, and therefore the trajectory of the Na+ ion through the receptor 
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to the cytoplasm is not obstructed by any significant energy barrier larger than the thermal energy of the 
system (kT.NA =  2.57 kJ mol-1, k: boltzmann constant, T: temperature (Κelvin), NA: avogadro’s constant) 
in the upward oriented Y4407.53. However, when the Y4407.53 is in the downward conformation, there is a 
slight but readily surmountable energy barrier (on physiological timescales) in the order of ~14 kJ mol-1. 
Interestingly, the downward conformation of the Y4407.53 sidechain in conjunction with the neutral state of 
D692.50 affects the shape and configuration of the hydrophilic pocket. The shape of the pocket under these 
conditions collapses slightly, shifting closer towards the structure seen within the active crystal structure, 
the resulting constriction of the Na+ ion within the pocket leads to a decrease in hydrogen bonds formed 
between the protein, water and the Na+ ion (Figure 4-12), which raises the free energy of binding at the 
hydrophilic pocket by a further ~7.5 kJ mol-1 (Figure 4-11 A, B red lines). 
 
Figure 4-12: Number of hydrogen bonds surrounding the Na+ binding site 
The conformation of the Y4407.53 sidechain and the D2.50 protonation state affect the number of hydrogen 
bonds within a 10 Å diameter sphere of the Cγ atom of D692.50, defining the binding region for Na+ and 
surrounding area. (A) With a charged D692.50 sidechain, a similar number of hydrogen bonds exist, 
irrespective of the conformation of Y4407.53. (B) In the case of neutral D2.50, the downward conformation 
of Y2627.53 leads to a decrease in the number of hydrogen bonds within the hydrophilic binding pocket. 
The number of hydrogen bonds was derived from the umbrella sampling window trajectories. Figure 
adapted from (156). 
 
To characterise the influence of the memebrane voltage, upon the free energy profile of the Na+ ion 
translocating from the hydrophilic pocket to the cytoplasm, I first calculated the gating charge arising from 
the movement, in 2.5 Å increments between the position of D1033.32 Cα and the cytoplasm. The movment 
of the Na+ ion from the Na+ binding site to the cytoplasm gives rise to a gating charge of ~0.45 e, in 
conjunction wth the conformational changes of the receptor. This is in excellent agreement with the inverse 
of this movement recorded in Chapter 3 (0.53 e). In a non-equilibrium case, such as a physiological Vm, the 
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energy will be raised in regard to the cytoplasm by ~4.4 kJ mol-1 per -100 mV (Figure 4-13). The PMFs 
show that regardless of the conditions tested with a neutral D692.50, the Na+ ion can readily transverse the 
hydrophilic channel in the receptor and permeate to the cytoplasmic side under physiological 
transmembrane voltages. However, when the Y4407.53 sidechain is in a downward conformation small 
activation barrier of ~7 kJ mol-1 will remain, but is surmountable in the physiological timescale.  
 
 
Figure 4-13: Non-equilibrium effect of Vm upon the PMF profiles of Na+ translocation to the 
cytoplasm 
Vm induced tilt of the free energy surface (Figure 4-11) of Na+ in a non-equilibrium case in the M2R under 
four different conditions: (A) Y4407.53 upward, D692.50 charged (B) Y4407.53 upward, D692.50 neutral (C) 
Y4407.53 downward, D692.50 charged (D) Y4407.53 downward, D692.50 neutral. Increments are from -250 
mV (light) to -1000 mV (dark); dotted line indicates 0mV. The underlying voltage drop was mapped using 
the gating charge calculations (E) derived from the M2R receptor with Y4407.53 upward and D692.50 
charged. The panels display the relative free energy differences for each voltage regime; the black bar 
denotes an energy difference of 10 kJ mol-1 within each panel. Figure adapted from (156). 
 
4.3 Conclusion 
 
The primary role of GPCRs is to transmit extracellular information across the membrane into the cytoplasm, 
activating a range of intracellular effectors (34, 57, 192). The activation process is known to involve 
conformation changes within the receptor, including the so-called “microswitches” as well as the large-
scale movement of the transmembrane helices 5, 6, and 7 on the intracellular side ultimately leading to the 
activation of the intracellular effectors proteins (130, 193–195). An interesting level of cooperativity exists 
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between the effector site and orthosteric ligand binding site, as it has long been recognised that effector 
binding and thereby the stabilisation of the active conformation, increases the affinity of agonists in the 
extracellular portion of the receptor (83, 196).  
 
Monovalent cations, in particular Na+, bind to a hydrophilic pocket deep inside the receptor, situated 
between the orthosteric ligand binding site and the intracellular effector binding site, and are known to be 
one of the strongest allosteric modulators in the Rhodopsin GPCR family (68, 107). Interestingly Na+ was 
found to negatively modulate the affinity of agonists, to their respective GPCRs, whilst having no effect on 
antagonists. The Na+ ion was proposed to stabilise the inactive conformation of the receptor (66, 68, 103). 
In support of this notion, x-ray structures of the inactive receptors crystallised at high resolution display a 
bound Na+ ion within the hydrophilic pocket bound to D2.50, while in the active crystals this pocket is 
collapsed, and no ions and very few waters molecules are observed (68, 130). The functionality of the 
Rhodopsin family of GPCRs are extremely sensitive to mutations surrounding the Na+ binding site, which 
have a major impact on the signalling of the receptor (197). They either abolish G-protein activation, result 
in extreme pathway biased signalling, or in constitutive ligand-independent signalling (65, 185, 197).  
 
My work throughout this chapter shows that the Na+ ion binding pocket situated at the base of hydrated 
pocket, can only be accessed from the extracellular solution in the inactive conformation (70, 177). By 
contrast, it is extended through the receptor forming a fully permeable and hydrated channel in the active 
form of the M2R. The channel connects the three core binding sites within Rhodopsin GPCRs: The 
orthosteric ligand binding site, the Na+ ion binding site and the intracellular effector binding site. Whilst 
the formation of a hydrated channel in the A2A and 5-HT1A receptors has been previously observed in 
simulations, change of protonation states and presence of the Na+ ion were not taken into account in those 
studies (69, 191). I show here that the shift of the receptor conformation from the inactive to the active, 
permits the Na+ ion to transverse the hydrated channel without experiencing any major energy barriers 
along its trajectory. The relatively high hydration level of this channel should be noted as an important 
factor in facilitating ion movement to the cytoplasm (Figure 4-8). The correlation between hydration and 
ion movement has previously been demonstrated in ion channels (173, 198, 199). This stands in stark 
contrast to simulations of the inactive state, where the application of far greater forces is necessary to 
achieve the translocation of Na+ towards the cytoplasm, due to the lack of a continuous hydrated channel, 
and therefore the need to break the hydrophobic layer (200).  
 
The translocation of Na+ to the cytoplasm is highly likely to be facilitated by a protonation state change of 
the D692.50 from the negatively charged deprotonated form to the neutral protonated form, which occurs 
upon small displacements of the ion from its preferential binding position. The neutralisation of D692.50 
significantly reduces the affinity of the Na+ binding pocket to Na+, increasing the likelihood of the ion 
migration to the cytoplasm. In physiological conditions the migration is predominantly driven by negative 
Vm and by a >10 fold Na+ gradient across the plasma membrane. These both propel the ion through to the 
cytoplasm in a synergistic manner, permitting permeation at lower driving forces. In corroboration, I 
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observed that mild hyperpolarised potentials are sufficient to allow for fast translocation of the Na+ ion to 
the Na+ binding site to the cytoplasm in the nanosecond timescale of our simulations (Table 4-1). 
 
 
Table 4-1: Permeation of Na+ into the cytoplasm and receptor hydration 
A complete list of simulations displaying the individual conditions: TM potential, the charge state of D2.50, 
observation of Na+ permeation to the intracellular side and the hydration of the receptor: the hydrophilic 
pocket, z = ±4Å from the D692.50 Cα atom and the hydrated channel between the z = -4Å from the D2.50 Cα 
atom and the z-coordinate of the R3.50 Cα. The number of water molecules were recorded every 2ns 
throughout the simulations. Table adapted from (156). 
 
In a brief summation of my results, the conformational changes arising from agonist binding from the 
extracellular solution and intracellular effector binding from the cytoplasmic side shifting the receptor to 
its active state, which modulates the shape of the Na+ binding pocket and thereby the interplay between the 
Na+ ion and D692.50. Subsequently, this leads to a shift in the pKa of D692.50 and therefore a protonation 
state change of the residue, facilitating the egress of the Na+ ion via the hydrated channel to the cytoplasm. 
 
4.3.1 GPCR activation 
 
I propose that the translocation of Na+ to the cytoplasm, facilitated by the hyperpolarised Vm and ionic 
gradients, is a crucial step in the receptor activation process. Once the Na+ has been expelled, the receptor 
may be locked in an active conformation, by the protonation of D2.50. It has been shown by several groups 
D2.50 charge 
state 
Transmembrane 
potential (mV) 
Replicate 
Na+ 
permeation 
Hydrophilic pocket 
hydration 
Effector pocket 
hydration 
Negatively 
charged 
(deprotonated) 
-250 
1 No 7.6±1.6 12.6±3.1 
2 No 7.5±1.6 15.8±2.7 
3 No 7.2±1.6 10.4±2.9 
4 No 6.7±1.3 12.1±4.1 
Negatively 
charged 
(deprotonated) 
-500 
1 No 7.9±1.4 14.6±2.6 
2 No 7.0±1.4 9.1±3.7 
3 Yes 7.9±1.8 15.2±3.1 
4 No 8.7±2.1 17.5±4.0 
Neutral 
(protonated) 
-250 
1 Yes 6.7±1.7 11.8±3.4 
2 Yes 7.2±1.8 15.1±4.0 
3 Yes 4.7±1.9 12.2±4.3 
4 No 7.6±1.6 16.4±3.5 
Neutral 
(protonated) 
-500 
1 Yes 6.9±2.0 15.9±3.5 
2 Yes 6.0±1.5 14.5±3.5 
3 Yes 5.5±1.7 14.8±3.3 
4 Yes 6.8±1.7 13.0±4.7 
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that GPCRs, once activated, remain in a prolonged active state, capable of signalling from intracellular 
organelles after internalisation from the cell membrane (41, 201). The key role of Na+ is reflected in the 
nearly complete conservation of the Na+ binding pocket across the entire Rhodopsin family. The mechanism 
suggested here is consistent with ligand-independent signalling (termed basal signalling) of GPCRs (202), 
explaining this phenomenon as spontaneous protonation of D692.50 and egress of the Na+ to the cytoplasm, 
leading to receptor activation (Figure 4-14). Throughout the ions transition to the cytoplasmic side, it is 
conceivable that the ion will interact with other key residues in the GPCR-cytoplasmic interface, and if the 
G-protein if bound, induce further conformational changes there. The interface includes a number of 
charged and polar residues (Figure 3-11), including a polar network which extends across all G-proteins, 
similar to the polar network observed within GPCRs, which helps enable ion movements (80, 203).  
 
 
Figure 4-14: Proposed role of Na+ translocation in GPCR activation 
Key checkpoints during the transition from the inactive (A) to active (D) state of the receptor. (A) The 
initial, inactive receptor conformation shows no bound agonist or G-protein, and displays a Na+ ion bound 
in a pocket which is sealed towards the cytosol by a hydrophobic layer around Y7.53. (B) G-protein and 
agonist bind to the receptor (in undetermined order), leading to the formation of a continuous water channel 
across the GPCR. The increased mobility of the Na+ ion results in a pKa shift and subsequent protonation 
of D2.50. (C) Neutralization of D2.50 and the presence of the hydrated pathway facilitate transfer of Na+ to 
the intracellular side, driven by the transmembrane Na+ gradient and the negative cytoplasmic membrane 
voltage. (D) The expulsion of Na+ towards the cytosol results in a prolonged active state of the receptor. 
Figure adapted from (156). 
 
As proposed by our simulations and pKa calculations, the movement of charges within the transmembrane 
domain such as the transfer of Na+ and protons, should be strongly influenced by the transmembrane 
voltage. As shown in the Chapter 3, as well as experimentally by other groups, it has been demonstrated 
that GPCR signalling is allosterically modulated by Vm (70, 112, 115, 116, 125, 168, 204). The expulsion 
of the Na+ ion in Chapter 3 by a depolarised Vm would consequently allow for the protonation of D2.50. The 
voltage sensitivity applies to the conformation of the receptor as well as the actual activation mechanism 
of the receptors downstream effectors. My results are consistent with the electrophysiological experiments 
described previously, as they imply that a movement of ions in the receptor are intimately linked to the 
activation process.   
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The allosteric regulation of GPCRs by Vm is potentially of high relevance to receptors expressed in 
electrically excitable cells (123, 205, 206). In these cells types, the Vm undergoes large oscillations between 
-90 and 50 mV during action potentials (120). The receptor can therefore regulate its downstream signal 
depending on the specific cell type and its excitation status (125). However, as described in Chapter 1 
section 1.5 the receptors signalling process can be modulated to an exquisite level by the surrounding 
environment such as membrane composition, pH, ionic composition and Vm. Thereby the receptor 
activation can be tuned to a far greater degree than individual cell types, but down to the spatial location 
within the cell and individual organelles (123, 207, 208).  
 
These results suggest a model for the activation of the Rhodopsin GPCR family, in which the 
conformational changes induced by either the binding of the intracellular effector and/or agonist are 
intertwined with the transfer of Na+ to the cytoplasm and protonation changes. Of importance, these 
conformational changes include the rearrangement of the motif NP7.50xxY, which when in an upward 
conformation permits a near barrier free permeation of Na+ to the cytoplasm. The residue Y7.53 is the first 
polar contact of the Na+ ion on the intracellular pathway, forming a functional link between the important 
motif and the Na+ binding site. Na+ free receptors are likely to be shifted to the active conformation, which 
could potentially explain the prolonged mechanisms of signalling observed in many GPCRs. Here, my 
results provide evidence linking signal transduction and the allosteric modulation by Vm, pH and Na+ 
concentration.    
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Chapter 5. The interplay between protonation and 
activation of the δ-OR  
 
5.1 Introduction 
 
As discussed within the previous chapters, GPCRs form the largest group of integral membrane proteins in 
the human genome (4). In the last few decades, GPCRs have been shown to signal via multiple pathways 
such as the classical G-protein, β-arrestin and kinase pathways (12). The δ-OR crystal structure (PDB: 
4N6H) was the second receptor in which the allosteric Na+ ion was seen, where it is coordinated by the 
conserved D2.50 (Figure 1-14)(65, 209). The Na+ binding site is part of a conserved hydrophilic pocket, of 
which only position 3.35 is the least conserved, with a balanced distribution of hydrophobic and hydrophilic 
residues (Chapter 1 section 1.4.2)(210). Interestingly, Fenalti et al. also mutated position 3.35 from 
asparagine in the wt δ-OR to either an alanine or valine. In both cases this resulted in a β-arrestin 
constitutively active receptor (65).  
 
Although the common mechanism of GPCR activation has yet to be identified, the activation mechanism 
in many GPCRs encompasses several features including TM domain movement, side chain movement, 
rearrangement of solvent clusters and hydrogen bond networks. Interestingly, the basal activity of GPCRs 
suggests that the activation energy of the receptor is low and not that much higher than thermal fluctuations 
(kT.NA =  2.57 kJ mol-1, k: boltzmann constant, T: temperature (Κelvin), NA: avogadro’s constant). If the 
activation energy were prohibitively higher than the thermal fluctuations then the receptor would be unable 
to activate in the absence of agonist binding (178).     
 
5.1.1 Allosteric modulation of the Rhodopsin GPCR family by pH 
 
An interesting feature which was alluded to in Chapter 4 is the effect of the protonation states of the three 
key titratable residues within the Rhodopsin GPCR family, D3.32, D2.50 and D/E3.49. A body of evidence 
exists, showing the effects of pH upon GPCR activation (96, 97, 178–180, 211). Predating any structural 
information, Ghanouni et al were able to demonstrate the effects of pH upon ligand binding and basal 
signalling. Upon lowering the pH they demonstrated that the basal signalling of the receptor increased 
whilst ligand binding decreased (96). Since then, computational studies on the protonation state of D2.50 
have reached a consensus: The sidechain of D2.50 is likely to be charged upon binding Na+ and neutral upon 
the removal of Na+ (176, 180, 212). Recently, effects of protonation upon the receptor were further 
demonstrated by the use of accelerated MD (aMD) to force the receptor into new conformations (176). 
However this study did not look at the key role of waters as well as the hydrogen bond network throughout 
the Na+ binding receptor.  
 
Throughout the previous two chapters, I showed that the movement of a cation from the hydrophilic pocket 
is possible under physiological conditions. The binding of a Na+ ion to the Na+ binding pocket has been 
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shown to drastically reduce the flexibility of the receptors, likely to confine them to more inactive 
conformations. In contrast, the absence of the Na+ ion increases receptor flexibility and allows it to sample 
more active conformations (176, 177). These previous results demonstrate a key role of the Na+ ion and its 
location within the Rhodopsin family of GPCRs. However, under experimental conditions it has been shown 
that the members of the Rhodopsin family are able to activate their cognate effectors under a wide range of 
voltages and ionic conditions. Therefore, whilst it conceivable that other mono- and divalent cations are able 
to bind, it is possible for these receptors to function in their absence (100, 212).   
 
5.1.2 Chapter overview 
 
Throughout this chapter, I will investigate the link between receptor activation and the protonation states 
of D2.50 and D3.49 using the δ-OR as a model system, including the previously described constitutive 
mutants, N1313.35A and N1313.35V (Figure 5-1). As I am looking exclusively at the effects of the protonation 
states and concurrently the effects of the single mutants. As I described in the previous chapters, the effects 
of Vm upon the receptor is conferred by the movement of the Na+ ion or proton within the Na+ ion binding 
pocket. In classical MD simulations the number of atoms and bonds remain constant, therefore the effect 
of Vm is applied artificially to the receptor. This approach allows the use of single bilayer simulations which 
allows for longer timescale simulations as well as a greater number of replicates due to the reduced number 
of atoms. 
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Figure 5-1: The δ-OR mutations and protonatable residues 
Depicted here is the δ-OR, highlighting the three protonatable aspartate residues-within the orthosteric 
ligand binding site (D3.32), the Na+ binding site (D2.50) and the D(E)R3.50Y (D3.49 ) motif are shown in purple. 
On the right hand side, the wt N1313.35 and the two mutated residues N1313.35A and N1313.35V are shown.      
 
5.2 Results 
 
More than 110 µs of atomistic simulations were conducted on the wt and mutant δ-OR with varying 
protonation states. For the wt δ-OR and the mutants N1313.35A and N1313.35V, three different protonation 
state configurations of the key titratable residues D952.50 and D1453.49 were simulated (Figure 5-1, Table 
5-1). The two titratable aspartates (D952.50 and D1453.49) were initially modelled in a negatively charged 
state due to their location where they interact with the counter charges of Na+ and R3.50 respectively.  
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Receptor 
Protonation State Total 
Simulation 
Time (μs) 
Number of 
Replicates D2.50 D3.49 
wt Charged Charged 16.62 4 
wt Neutral Charged 12.39 4 
wt Neutral Neutral 11.7 4 
N1313.35A Charged Charged 17.18 4 
N1313.35A Neutral Charged 12.28 4 
N1313.35A Neutral Neutral 11.21 4 
N1313.35V Charged Charged 2.80 1 
N1313.35V Neutral Charged 12.26 4 
N1313.35V Neutral Neutral 11.35 4 
 
Table 5-1: Simulation conditions specifying the protonation states of D952.50 and D1453.49. 
A complete list of simulations displaying the individual conditions: the mutation of N1313.35, the 
protonation state of D952.50 and D1453.49.  
 
5.2.1 Receptor stabilisation by the negatively charged D952.50 and D1453.49 
 
As previously described in Chapter 3, the Na+ ion remains bound to the negatively charged D952.50, with 
increasing fluctuations in the mutant receptors compared to the wt δ-OR (Figure 5-2). As no Vm is applied 
to these systems, the Na+ ion does not leave the Na+ binding pocket. However, the Na+ ion undergoes brief 
excursions to the orthosteric ligand-binding site coordinated by the sidechain of D1283.32 in the N1313.35A 
mutant (Figure 5-2 B). The free energy profiles shown in Chapter 3 (Figure 3-4) show the Na+ ion in the 
wt receptor is predominantly coordinated in ABS-1 with brief fluctuations to ABS-2. This is supported by 
observations in Figure 5-2 A, by contrast, the PMF for the N1313.35V mutant displays a broader energy 
minimum around the Na+ binding pocket (Figure 3-4 B), which is reflected by the fluctuations in Figure 
5-2 C. As the modulation of Na+ binding by the δ-OR mutants are well described within Chapter 3, I focused 
upon the effects of the δ-OR mutants and varying protonation state upon three key domains and 
microswitches within the receptor: the Na+ binding pocket, NP7.50xxY and the D(E)R3.50Y motifs (see 
section 1.4). 
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Figure 5-2: Effect of the N1313.35 mutation upon Na+ binding 
Z-coordinate of the allosteric Na+ ion bound within the Na+ binding pocket in the wt δ-OR (A), N1313.35A 
δ-OR mutant (B) and the N1313.35V δ-OR mutant (C). This figure shows the increasing destabilisation of 
the Na+ ion within the N1313.35 mutant receptors. For all trajectories see Appendix Figure 8-1. 
 
 
Figure 5-3: Key Na+ binding site residues in the δ-OR 
The inactive δ-OR, displays a stable interaction pattern within the Na+ binding site. Depicted here are the 
initial orientations of N3107.45 and N3147.49 in which the carboxyl and amide groups face D952.50, 
respectively. Shown here is the ultra conserved water molecule mediating the hydrogen bond network 
between N671.50, D952.50 and Y3187.53. Hydrogen bonds are shown as dashed black lines.  
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The initial inactive conformation δ-OR displays a highly stable Na+ binding pocket. The Na+ binding site 
contains two core components. First, the conserved water molecule mediating the hydrogen bond network 
between N671.50, D952.50 and Y3187.53. Secondly, the conformations of N3107.45 and N3147.49, in the inactive 
conformation they are oriented so that their carboxyl and amide groups face the residue D952.50, respectively 
(Figure 5-3).  
 
The side chains of N3107.45 and N3147.49 within the Na+ binding pocket undergo no significant movements 
from the initial inactive conformation in the wt δ-OR. The side chains of residues N3107.45 and N3147.49 
display exceptional stability in the inactive conformation (Figure 5-3 and Figure 5-4). In the δ-OR mutants 
N1313.35A and N1313.35V, the greater fluctuation of the ion within the Na+ binding pocket destabilises the 
sidechains of N3147.49. In these simulations the carboxyl group of N3147.49 reorients to coordinate the Na+ 
ion when it moves deeper within the pocket (Figure 5-4 B and C). This effect is seen to a greater extent in 
the N1313.35V δ-OR mutant due to the Na+ ion being situated lower in the pocket (Figure 5-2 and Figure 
5-4 C).  
 
 
Figure 5-4: Effects of a charged D952.50 and D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Shown here is the slight 
destabilisation of the Na+ binding pocket upon mutation of N1313.35, in contrast to the wt receptor. For all 
trajectories see Appendix Figure 8-2. 
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To monitor the conformational shift from the inactive receptor to the active state, I will use three distance 
measurements as activation criteria. To date, there is no active state crystal structure of the δ-OR and 
therefore I will use the active μ-OR crystal structure (PDB ID: 5C1M) as a guide, describing the activated 
receptor conformation (Figure 5-5, (190)). So far, all active state structures show similar conformational 
features (for review see reference 215). 
 
Figure 5-5: Crystal structure of the active state μ-OR 
Depicted here is the μ-OR (silver), highlighting residues involved in the activation of the receptor. The 
three protonatable aspartate residues within the orthosteric ligand binding site (D3.32), the Na+ binding site 
(D2.50) and the D(E)R3.50Y (D3.49 ) motif are shown in purple. The sidechain of Y7.53 is shown here in the 
horizontal conformation, and the R3.50 is shown in the extended state pointing towards the Cα of Y7.53. A 
bound nanobody to the G-protein binding site stabilising the active state is shown in green. (PDB ID: 
5C1M).        
 
As demonstrated in Chapter 4, the activation of the receptor induces the movement of TM 5 and 6 away 
from the core of the receptor. Therefore, here I use a measure of the distance between the intracellular 
domain of TM 6 and TM 2 (T842.39-Cα: I2596.33-Cα distance, μ-OR guide cut-off: 15 Å). Furthermore, in 
active GPCRs the sidechain of Y7.53 is oriented in a horizontal conformation facing across the intracellular 
effector-binding site. Therefore, the second activation criterion employed is the sidechain conformation of 
the residue Y3187.53 in the NP7.50xxY motif as captured by the distance between Y3187.53-OH: D952.50-Cα 
(μ-OR guide cut-off: 12 Å). In active state GPCRs, the sidechain of R3.50 is released from its compact 
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inactive state to extend into the intracellular effector-binding site. The third activation criterion I monitored 
is the sidechain of R1463.50 in the D(E)R3.50Y motif (R1463.50-CZ: Y3187.53-Cα distance, μ-OR guide cut-
off: 8 Å). In order for the receptor to be classified as an active state and not an intermediate state, all three 
of the above criteria must be met.  
 
Within the wt and N1313.35V δ-OR mutant, the receptor displays no significant movement towards the 
active state in this protonation regime. The microswitches within the D(E)R3.50Y and NP7.50xxY motifs 
stably remain in the inactive conformation (Figure 5-6).  
 
 
Figure 5-6: Effects of a charged D952.50 and D1453.49 upon the activation of the δ-OR 
The criteria for the activation of the δ-OR receptor. With a negatively charged D952.50 and D1453.49, both 
the wt and two δ-OR mutants (A-C) do not deviate from their inactive state. Shown is the distance between 
Y3187.53-OH and D952.50-Cα (blue), R1463.50-CZ and Y3187.53-Cα (red), and T84-Cα and I259-Cα (black). 
For all trajectories see Appendix Figure 8-3. 
 
5.2.2 Receptor destabilisation by the protonation of D952.50  
 
The initial simulations within section 5.2.1 provide a base line against which the effects of varying 
protonation states can be compared. The Na+ ion and therefore a putatively charged D2.50 have been 
proposed to stabilise the inactive conformation of the receptor, this was seen within Chapter 4 and has been 
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demonstrated in refs (66, 68, 103). As described in Chapter 4, the active receptor displays a collapsed Na+ 
binding pocket, which is unlikely to be favourable for cation binding (64, 74, 190). Therefore, based upon 
the pKa calculations reported in the previous Chapters which showed that D2.50 is likely to be protonated 
without its counter ion (Na+), I removed the bound Na+ ion from the Na+ binding pocket and simulated the 
three previously described δ-Opioid receptor variants with a protonated D952.50.  
 
Interestingly, protonation of the residue D952.50 destabilises the positions of two asparagine residues within 
the Na+ binding pocket, causing the orientation of N3107.45 to reverse (Figure 5-7). Within the wt and the 
mutant δ-ORs, the interactions between the N3107.45 sidechain and D952.50 are disrupted, allowing the 
sidechain move away from D952.50 by ~1-2 Å (Figure 5-13 B). The strong hydrogen bond network between 
sidechains of D952.50, N3107.45 and N3147.49 is also disrupted, increasing the flexibility of the N3147.49 
sidechain. In contrast to the sidechain of N3107.45, N3147.49 displays far greater flexibility. The head group 
of residue N3147.49 can rotate by approximately 90o,  allowing either the amide or carbonyl group of 
N3147.49 to displace the hydrogen bond between Y3187.53-OH and the highly conserved water molecule 
(Figure 5-3 and Figure 5-13, B).   
 
 
Figure 5-7: Effects of a neutral D952.50 and charged D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Destabilisation of the Na+ 
binding pocket upon the protonation of D952.50. For all trajectories see Appendix Figure 8-4.   
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Despite the rearrangement of the Na+ binding pocket, these changes are not propagated into a fully activated 
conformation of the receptor. Interestingly, due to the increased flexibility of N3147.49 the sidechain of 
Y3187.53 displays an increased conformational variability (Figure 5-8). Throughout the simulations in which 
D952.50 is protonated, the sidechain of Y3187.53 can occupy four main conformations: The inactive 
conformation in which the Y3187.53 is locked in an upright conformation via a three way hydrogen bond 
between N671.50, D952.50 and Y3187.53 mediated by a highly conserved water molecule (corresponding 
distance: ~8 Å, Figure 5-13, A). Upon N3147.49 disrupting the previously described hydrogen bond network, 
an intermediary conformation is seen (corresponding to a distance of ~10 Å, Figure 5-13, B). Thirdly, a 
downward conformation is observed in which the sidechain faces towards the intracellular binding site. 
This conformation is stabilised by the Y3187.53-OH group forming a hydrogen bond with the carboxyl group 
of N852.40, this conformation has also been reported for the intermediate active state of the A2A receptor 
(PDB ID: 2YDV, (72))(corresponding distance: 16 Å, Figure 5-13, C). Fourthly, a horizontal conformation 
is observed, in which the sidechain of Y3187.53 faces across the core of the receptor towards TM 3, similar 
to that reported in Chapter 4 and in the active crystal structure of the μ-OR (corresponding to a distance of 
14 Å, Figure 5-13, D). Interestingly, the D(E)R3.50Y motif displays fluctuations to the active state to a 
slightly greater degree within the N1313.35 mutants. However, no movement to the fully activated 
conformation is seen. 
 
 
Figure 5-8: Activation criteria for the δ-OR with a neutral D952.50 and charged D1453.49 
The criteria for the activation of the δ-OR receptor. With a neutral D952.50, both the wt and two δ-OR 
mutants (A-C) do not fulfil the criteria for the active conformation. The protonation of D952.50 however 
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increases the conformational flexibility of Y3187.53, in which the inactive, intermediate and downward 
conformation is observed. Shown is the distance between Y3187.53-OH and D952.50-Cα (blue), R1463.50-CZ 
and Y3187.53-Cα (red), and T84-Cα and I259-Cα (black). For all trajectories see Appendix Figure 8-5. 
 
5.2.3 Activation of δ-OR by the protonation of D952.50 and D1453.49 
 
The third ionisable residue within the δ-OR is part of the highly conserved D(E)R3.50Y motif. The aspartate 
residue (D1453.49) within this motif has been proposed to be responsible for pH-dependent activation (214, 
215). Therefore, D1453.49 in conjunction with D952.50 was modelled in a neutral state. Similar, to the 
previous section, I observed a destabilisation of the Na+ binding site (Figure 5-9). Both, N3107.45 and 
N3147.49 display a greatly increased conformational freedom in comparison to the charged D952.50 
simulations. In the majority of simulations, the sidechain of N3107.45 exists in two predominant orientations 
as previously described, whilst the sidechain of N3147.49 displays the same conformational variation as 
described in the previous section.  
 
 
Figure 5-9: Effects of a neutral D952.50 and D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Destabilisation of the Na+ 
binding pocket upon the protonation of D952.50 and D1453.49. For all trajectories see Appendix Figure 8-6.    
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In contrast to the previous sections, in the protonated state there are large-scale rearrangements of the 
receptors corresponding to activation. The movement towards the activated conformation occurs regardless 
to the mutation state of N1313.35, with both the wt δ-OR and N1313.35A mutant undergoing the full transition 
between states. The analysis of the doubly protonated receptor simulations display the fulfillment of all 
three activation criteria. The R1463.50 sidechain displays an increased propensity to extend into the 
intracellular effector-binding site. The distance between the head group of R1463.50 and Y3187.53-Cα 
decreases from 14 Å to 8-10 Å (Figure 5-10). Interestingly, the movement of the D(E)R3.50Y and NP7.50xxY 
motif moving to the active conformation results in an increase in distance between TM 2 and 6. The distance 
between helices increases from ~8 Å to up to ~16 Å (Figure 5-10 A, B, Figure 5-11 D).  
 
 
Figure 5-10: Activation criteria for the δ-OR with a neutral D952.50 and D1453.49 
The criteria for the activation of the δ-OR receptor. With a neutral D952.50 and D1453.49, both the wt and 
N1313.35A δ-OR mutant (A-B) fulfil the criteria for the active conformation. The protonation of D952.50 
increases the conformational flexibility of Y3187.53, in which all four conformations are observed. The 
R1463.50 sidechain extends into the G-protein binding pocket, and a corresponding increase in distance 
between TM 2 and 6 is seen. Shown is the distance between Y3187.53-OH and D952.50-Cα (blue), R1463.50-
CZ and Y3187.53-Cα (red), and T84-Cα and I259-Cα (black). For all trajectories see Appendix Figure 8-7. 
 
As previously described in Chapter 4 and ref. (69), the activation of the receptor leads to the formation of 
a hydrated channel connecting the Na+ binding site to the intracellular bulk solution. The neutralisation of 
both D952.50 and D1453.49 results in the widening of TM 2-6, breaking the hydrophobic layer and thus 
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allowing the ingress of water from the extracellular and intracellular solutions. The number of water 
molecules within the water channel increases from an average of 1.5 in the inactive states, in which the 
water molecules are stably bound. Whilst in the active receptor the number of water molecules increases to 
an average of 6.5 ± 2.5 and 6.4 ± 2.9 in the wt and N1313.35A δ-OR active receptor, respectively (Figure 
5-11)    
 
 
Figure 5-11: Hydration of the intracellular channel 
The hydration of the hydrophobic layer upon δ-OR activation. (A, B) depict the increased hydration upon 
the activation of the receptor. The increased hydration level is linked to the conformational changes of the 
NP7.50xxY and D(E)R3.50Y motifs (Figure 5-10 A, B). (C) None of the N1313.35V mutants moved to the 
active state, therefore depicted here is an example of the normal hydration of the non channel forming 
hydrophobic layer (~1.5 water molecules). The water molecules were counted every 10 ns, between a 
distance of z = -4Å from the D952.50 Cα atom and towards the intracellular with the z-coordinate of the 
R1463.50 Cα. (D) Shown here is a comparison of the inactive (silver) and active (blue) conformations arising 
from the protonation of D952.50 and D1453.49. The movements of TM 5 and 6 are highlighted here. For all 
trajectories see Appendix Figure 8-8.  
 
5.3 Conclusion 
 
The principal role of GPCRs is the transmission of extracellular information through the receptor to the 
cytoplasm, and the subsequent activation of intracellular effectors (34, 57, 192). The activation process of 
the receptor is known to involve a range of conformational changes, from large scale movements such as 
the rearrangement of TM 5, 6, and 7 on the intracellular side to small sidechain rearrangements in the 
microswitches (130, 193–195). It has long been known that the Rhodopsin GPCR family is sensitive to a 
range of environmental factors, including Vm, pH, Na+ ions (see section 1.5). The effects of pH upon the 
upon basal signalling and agonist induced activation in the β2AR and rhodopsin have been well described 
(96, 215). However, whilst the majority of ionisable residues in the Rhodopsin GPCR family are solvent 
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exposed and are therefore likely to have a pKa far away 7. In contrast, residues buried within the TM section 
have an up shifted pKa and can therefore titrate upon smaller deviations from pH 7. The Rhodopsin GPCR 
family contains three acidic residues within the transmembrane domain: D2.50, D3.32 and D3.49. Of these 
three, only the protonation of D2.50 and D3.49 has been studied (96, 216, 217). However, mutation of these 
residues severely disrupts the signalling of GPCRs, making experimental results difficult to interpret (see 
section 1.4).  
 
In Chapter 3, I demonstrated that the experimentally measured gating charge is likely to arise from the 
transfer of either a proton or the allosteric Na+ ion to or from the receptor. In Chapter 4, I showed that the 
protonation state of D2.50 is strongly modulated by the location of the Na+ ion. The µs timescale atomistic 
simulations of the wt δ-OR as well as the two δ-OR mutants N1313.35A and N1313.35V demonstrate the key 
role of D2.50 and D3.49 protonation states in the activation of the δ-OR. The results demonstrated here 
showing the conformational shift of the receptor to the active state upon the protonation of key residues 
(Figure 5-12), is in excellent agreement with experiments where the basal signalling is increased upon 
lowering the pH (96, 214). Due to the conservation of the residue D2.50 in the Na+ binding pocket, and of 
an acidic residue within the D(E)R3.50Y motif, the proposed protonation pattern is highly likely to be 
applicable to the rest of the Rhodopsin GPCR family.  
 
99 
 
Figure 5-12: Comparison of the μ-Opioid crystal structure and the active MD δ-Opioid receptors  
Shown here is a comparison of the active crystal of the μ-OR (silver) with a nanobody bound (green) and 
active δ-OR (blue) conformations arising from the protonation of D952.50 and D1453.49. The sidechains R3.50 
and Y7.53 are depicted in both the μ-OR (violet) and δ-OR (cyan).  
 
Interestingly, I did not see any significant difference between the wt δ-OR and the N1313.35A and N1313.35V 
δ-OR mutants. With the exception of the Na+ bound receptors, in which the Na+ binding pocket displayed 
increasing destabilisation upon the mutation of N1313.35. Though the mutant δ-ORs did display some 
increased mobility within the D(E)R3.50Y motif regardless of the protonation states when compared to the 
wt receptor, all motions were below the threshold for activation (Fig 11-15). The changes to the receptor 
may be too subtle for the simulations to detect, however these simulation can be mined for more detailed 
differences. For a continuation of this work, it would be interesting to test the sole protonation of D1453.49 
as well as any changes in the TM 3 in which the mutant is situated. To this end, the conclusions presented 
here are a common mechanism across all three δ-OR systems. 
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5.3.1 Signal propagation from Na+ binding site to the G-protein binding site  
 
The sequential protonation of D952.50 within the Na+ binding site and D1453.49 in the D(E)R3.50Y motif 
demonstrates how small changes in the receptor can propagate into large scale conformational changes 
(Figure 5-13). The initial protonation of D952.50 modulates the shape of the Na+ binding pocket, in particular 
the tight interaction of D952.50 and N3147.49 (Figure 5-13 A). The breaking of the hydrogen bond between 
D952.50 and N3147.49, consequently allows for the disruption of the three-way hydrogen bond between 
N671.50, D952.50 and Y3187.53 (Figure 5-13 B), which is mediated by a highly conserved water molecule 
(Figure 5-3). The importance of this water molecule is reflected in its presence in nearly all crystal structures 
of the Rhodopsin GPCR family irrespective of their activation state (68). The disruption of the water-
mediated hydrogen bond within the Na+ binding pocket allows two possible active sidechain conformations 
of Y3187.53. The first is the rotation into a downward conformation interacting with the intracellular end of 
TM 2 (N852.40). This downward conformation is likely seen only in the absence of the intracellular binding 
partner. The second is the formation of a horizontal conformation facing TM 5 (Figure 5-13 D). This 
conformation is highly similar to that reported in the active μ-OR crystal structure (PDB ID: 5C1M, (190)). 
The sidechain of Y2335.58 was proposed to stabilise the active conformation by facing the core of the 
receptor and coordinating with the horizontal conformation of Y3187.53 (see section 1.4.3). However, 
throughout all simulations regardless of the protonation states and mutations, the sidechain of Y2335.58 
adopts two predominant conformations an inward pose facing the core of the receptor and an outward facing 
conformation.  
 
The protonation of D1453.49 in conjunction with the protonation of D952.50 results in the activation of the 
D(E)R3.50Y motif. The extension of the R1463.50 towards TM 7, aids in the hydration of the hydrophobic 
layer and the formation of the water channel seen within Chapter 4. This subsequently results in the outward 
conformational shift of TM 5 and 6 seen within all active crystal structures.    
101 
 
Figure 5-13: Propagation of activation arising from protonation changes 
The sequential activation of the δ-OR by the protonation of D952.50 and D1453.49. (A) Displays the initial 
conformation of the Na+ binding pocket and Y3187.53 in the inactive form. (B) The intermediary 
conformation of the Y3187.53, in which the N3147.49 has displaced the hydrogen bond between Y3187.53 and 
the conserved water. (C) The Y3187.53 in a downward conformation coordinated with N852.40. (D) The 
horizontal conformation of Y3187.53 sidechain, demonstrated here is the increased hydration of the 
hydrophobic layer. It should be noted that in A and B the side chain of N3107.45 is in the initial orientation 
(distance = 2 Å), in panel C and D in the orientation is now inverted (distance = -2 Å). The sidechains of 
the protonatable residues D952.50 and D1453.49 are depicted in cyan. All pertinent hydrogen bonds are 
depicted by dashed black lines. 
  
These simulations demonstrate the importance of the internal hydration and hydrogen-bonding pattern 
within the receptor (80). The results suggest a mechanism for the Na+ free activation of the δ-OR, in which 
the protonation of D952.50 and D1453.49 play an intrinsic role. Protonation induced conformational changes 
are also in agreement with the Vm induced changes seen by experimental studies (184). The pKa of D2.50 
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and D3.32 was shown to ~10-11 under equilibrium conditions (Chapter 4). As both of these residues are 
located in the transmembrane domain, their pKa is highly likely to be strongly modulated by changes in the 
Vm (181). These acidic residues within the transmembrane domain are likely to be protonated in a 
hyperpolarised potential, however, upon depolarisation of the membrane the pKa of these residues is likely 
to be downshifted enough to become deprotonated. As I have previously described, this is sufficient to 
cause the receptor to undergo significant conformational changes within the highly conserved motifs and 
large-scale movement of TM 5 and 6.    
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Chapter 6. Closing remarks 
 
6.1 Thesis summary 
 
The overall aim of this thesis was to study the allosteric effects of the internally bound Na+ ion, protonation 
(D3.32, D2.50 and D3.49) and Vm upon the Rhodopsin GPCR family. This thesis is separated into three main 
results; the first describes the movement of either a Na+ ion or proton from the Na+ binding site to the 
extracellular solution. The movement of the cation was demonstrated to be possible under physiological 
depolarised Vm conditions. The gating charge arising from this movement is in excellent agreement with 
previous experimentally recorded gating charges (Chapter 3). Therefore, my findings offer mechanistic 
insight into GPCR voltage dependence. 
 
The active crystal structures of the Rhodopsin GPCR family display a collapsed Na+ ion binding site. The 
resulting conformation of the pocket is thought to preclude the binding of the Na+ ion. Here, I demonstrate 
that it is possible for the Na+ ion to pass through the hydrophobic layer to the cytoplasm. I show by Potential 
of Mean Force calculations that the synergistic physiological driving force of the Na+ concentration gradient 
and hyperpolarised Vm is sufficient to drive ion permeation. The Na+ ion was found to be strongly coupled 
to the protonation state of the key Na+ binding residue D2.50. Small movements of the Na+ ion resulted in a 
pKa shift of ~6 units. Following the protonation of D2.50, the passage of the Na+ to the cytoplasm was shown 
to be near barrier free (Chapter 4).  
 
Point mutations within the Na+ binding site have been demonstrated to drastically alter the receptors 
signalling pattern. In the δ-OR, I studied the effects of the constitutively active mutants N1313.35A and 
N1313.35V upon the receptor conformation. Concurrently, I sequentially changed the protonation states of 
the D952.50 and D1453.49 in the Na+ binding site and D(E)R3.50Y, respectively. The neutralisation of D952.50 
resulted in the increased flexibility of the NP7.50xxY motif, and the subsequent neutralisation of D1453.49 
leads to the large-scale conformational change of the receptor from the inactive to active state. Here, I 
proposed a mechanism in which the protonation of D952.50 is propagated into the activation of the receptor 
(Chapter 5).       
 
6.2 Revised concepts 
 
The original interpretation of each Chapter’s results has evolved with additional information. Within 
Chapter 3, I demonstrated that the movement of a cation from the Na+ binding site to the extracellular 
solution gives rise to a gating charge (0.53 e) in excellent agreement to the previous experimentally 
measured the gating charges (0.55 - 0.85 e)(125). In Chapter 3, I originally considered that the gating charge 
arose from the translocation of the Na+ ion due to the concentration of Na+ within the extracellular solution. 
However, the inclusion of the pKa calculations done in Chapter 4, demonstrating that Vm induced 
protonation and deprotonation of D2.50 is highly likely. The probability of the gating charge arising from a 
protonation change of D2.50 is increased by the use of monovalent cation free solutions in the experiments. 
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The mutation of D2.50 abolishes the gating charge in the Rhodopsin GPCR family. This is in agreement with 
our simulations that the movement of a Na+ ion or proton from the Na+ binding site gives rise to the gating 
charge. 
 
Although the mutation of D2.50 to an asparagine abolishes the gating current in the m1 muscarinic receptor 
(M1R), its ligand binding affinity is still modulated by voltage (218). In Chapter 4, the pKa calculation of 
the aspartate that is required for binding of the muscarinic ligands (D3.32), reveals that in the apo form this 
residue is in a protonated state, whilst upon ligand binding the pKa is lowered to ~7. The aspartate is within 
the transmembrane electric field, and therefore it is possible for the pKa of D3.32 to be modulated by Vm. 
This modulation could give rise to the ligand dependent voltage effects seen. The sensitivity of D3.32 to the 
physiological environment demonstrated by its sensitivity to extracellular pH. In the β2AR, the basal 
signalling of the receptor increases, whilst the agonist binding affinity decreases upon the lowering of the 
extracellular pH from 8 to 6.5 (96). This is likely due to the protonation of D3.32 preventing the negative 
charge of the aspartate from stabilising the positively charged ligand, whilst simultaneously, increasing the 
likelihood of the protonation of D2.50 and thereby stabilising the active state of the receptor. In Chapter 5, I 
demonstrate that the receptor can shift to the active state upon the protonation of D2.50 and D3.49. This also 
is in excellent agreement with the pH sensitivity of β2AR (96). The protonation-induced conformational 
change similarly is in agreement with the Vm induced conformation change of the receptor. 
 
6.3 Future directions 
 
The current simulations provide a potential explanation for the regulation of GPCRs by pH, Vm and Na+ 
ions. However, the continuation of this work can be undertaken on a two-pronged approach, a 
computational and experimental. 
 
To be able to include the Vm into the pKa calculations would enable a clearer insight into the role of D3.32 
in ligand dependent voltage sensitivity. This would also be of benefit to studying the protonation states of 
D2.50 and D3.49. The inclusion of quantum mechanical/molecular mechanics (QM/MM) simulations would 
allow for a more in depth study of the role of proton transfer within Rhodopsin GPCRs. Whilst the work 
presented within this thesis is focused predominantly on the Na+ and protonation states of key acidic 
residues, a comprehensive study on the Na+ binding site would be enlightening, in particular; A comparison 
of the hydrogen bond network between the inactive and active structures. The interaction pattern between 
water molecules and key amino acids could be elucidated by further mutational studies on the residues of 
the Na+ binding pocket, in particular positions 2.50, 3.35, 7.45 and 7.49. 
 
There are multiple experiments, which can be undertaken to study the Vm related allosteric effects arising 
from changes in protonation state. The majority of voltage allostery studies have been performed in 
receptors containing an aspartate at position 3.32. Therefore, to test the role of a protonatable residue on 
the ligand dependent voltage effects, experiments should to be undertaken using receptors without an 
aspartate at position 3.32 or the use of ligands, which are not dependent on this residue for binding. The 
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characteristics of the gating charges in GPCRs should be modulated by changes in the extracellular pH, and 
therefore it would be interesting to see the gating charges arising from an altered pH and the receptor 
mutants previously described.    
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Chapter 8. Appendix 
 
 
 
 
Appendix Figure 8-1: Effect of the N1313.35 mutation upon Na+ binding 
Z-coordinate of the allosteric Na+ ion bound within the Na+ binding pocket in the wt δ-OR, N1313.35A and 
the N1313.35V δ-OR mutants. This figure shows the increasing destabilisation of the Na+ ion within the 
N1313.35 mutant receptors.  
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Appendix Figure 8-2: Effects of a charged D952.50 and D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Shown here is the slight 
destabilisation of the Na+ binding pocket upon mutation of N1313.35, in contrast to the wt receptor.  
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Appendix Figure 8-3: Activation criteria for the δ-OR with a charged D952.50 and  D1453.49 
The criteria for the activation of the δ-OR receptor. With a negatively charged D952.50 and D1453.49, both 
the wt and two δ-OR mutants do not deviate from their inactive state. Shown here the distance between 
Y3187.53-OH and D952.50-Cα (blue), R1463.50-CZ and Y3187.53-Cα (red), and T84-Cα and I259-Cα (black). 
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Appendix Figure 8-4: Effects of a neutral D952.50 and charged D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Demonstrated here, is the 
destabilisation of the Na+ binding pocket upon the protonation of D952.50.  
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Appendix Figure 8-5: Activation criteria for the δ-OR with a neutral D952.50 and charged  D1453.49 
The criterion for the activation of the δ-OR receptor. With a neutral D952.50, both the wt and two δ-OR 
mutants do not fulfil the criteria for the active conformation. The protonation of D952.50 increases the 
conformational flexibility of Y3187.53, in which the inactive, intermediate and downward conformation is 
observed. The distance between Y3187.53-OH and D952.50-Cα (blue), R1463.50-CZ and Y3187.53-Cα (red), 
and T84-Cα and I259-Cα (black). 
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Appendix Figure 8-6: Effects of a neutral D952.50 and D1453.49 upon the Na+ binding pocket 
The dihedral angle χ2 of the N3107.45 (blue) and the N3147.49 (red) sidechains. Demonstrated here, is the 
destabilisation of the Na+ binding pocket upon the protonation of D952.50 and D1453.49. 
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Appendix Figure 8-7: Activation criteria for the δ-OR with a neutral D952.50 and  D1453.49 
The criteria for the activation of the δ-OR receptor. With a neutral D952.50, both the wt and two δ-OR 
mutants (A-C) do not fulfil the criteria for the active conformation. The protonation of D952.50 increases 
the conformational flexibility of Y3187.53, in which the inactive, intermediate and downward conformation 
is observed. The distance between Y3187.53-OH and D952.50-Cα (blue), R1463.50-CZ and Y3187.53-Cα (red), 
and T84-Cα and I259-Cα (black). 
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Appendix Figure 8-8: Hydration of the hydrophobic layer 
The hydration of the hydrophobic layer upon δ-OR activation. The water molecules were counted every 10 
ns, between a distance of z = -4Å from the D952.50 Cα atom and towards the intracellular with the z-
coordinate of the R1463.50 Cα. 
